383/2007 Sb.
DECREE
of 19 December 2003. December 2007,
on the determination of the values of the point, the amount of the reimbursement of health care by
health insurance and regulatory limits on the volume provided by health
care paid for by public health insurance for the year 2008
The Ministry of health shall lay down pursuant to § 17 para. 6 of Act No. 48/1997
Coll., on public health insurance and amending and supplementing certain
related laws, as amended by Act No 117/2006 Coll., no 245/2006 Sb.
and no. 261/2007 Coll. (hereinafter the "Act"):
§ 1
(1) this Ordinance shall, for the year 2008, the point values, the amount of remittances
the health care provided to the insured under section 2 (2). 1 of the law (hereinafter
"insured person competent health insurance company") and the affiliated persons of the
the other Member States of the European Union, the European economic
area and Switzerland according to relevant regulations of the European
Community ^ 1) and the insured of other States with whom the United
Republic concluded international agreements on social security (^ 2)
"the beneficiary of EU"), paid for by public health insurance and
the regulatory limits on the volume of health care provided
and) in contractual healthcare facilities in institutional care, including
specialised therapeutic institutes for long-term patients, hospitals,
medical device reporting treatment day no. 00005 according
the Decree issuing the list of medical procedures with spot
the values of ^ 3) (hereinafter referred to as "power list"), and medical devices
the hospice type according to § 22a of the Act,
b) Contracting General practitioners for adults and for general practitioners
children and adolescents,
(c)) in contractual outpatient health care facilities providing
specialized outpatient medical care, including outpatient
health care facilities providing health care and hemodialysis
ortoptickou health care
d) Contracting dentists,
e) in contractual outpatient health care facilities providing
health care in the fields of medicine, 801, 802 222, 804, 805, 807, 809, 812-
819, 822 and 823, according to the list of services (hereinafter referred to as "listed
the skill "),
(f)) in contractual outpatient health care facilities providing
health care in the fields of medicine, 921 911 and 925, according to the list of performances
g) in contractual outpatient health care facilities providing
health care in 902 by the skill list of performances
h) Contracting healthcare emergency medical services,
medical transport and providing medical first aid service,
I) Contracting healthcare Spa care and ozdravovnami,
(j)) in the context of emergency care in non-medical
devices for methods of payment referred to in § 2 to 14.
(2) If a health care facility and a health insurance company agree on the
Another method of payment than stated in § 2 to 13, the agreed level of remuneration
under this method of payment must not be in conflict with health insurance
health insurance plan.
§ 2
For the health care provided by the medical devices specified in §
1 (1). 1 (b). a) to (j)), paid according to the list of performance shall be the
point value equal to 0.90 €, if not stipulated otherwise.
§ 3
(1) For health care provided by health establishments of the constitutional
care, with the exception of health care provided by specialised therapeutic
institutes, institutes for long-term patients in health care facilities
returning the treatment day no. 00005 according to the list of performances and in
Healthcare hospice type, point value, the amount of remittances
health care and regulatory restrictions set out in annex 1 to this
the Decree.
(2) For health care provided by specialised therapeutic institutes,
a sanatorium for long-term patients in health care facilities
returning the treatment day no. 00005 according to the list of performances and in
Healthcare hospice type, paid a flat rate per
one day of hospitalization, or according to the list of services, the value of point,
the amount of the reimbursement of health care and regulatory restrictions set out in annex 1 to the
This Decree.
§ 4
For the health care provided by general practitioners for adults and
General practitioners for children and adolescents, by the combined kapitačně
the performance payment, combined with kapitačně power payment
by calling kapitace or by list of performances, with the point value, the amount of
reimbursement of health care and regulatory restrictions set out in annex 2 to this
the Decree.
§ 5
For specialised outpatient healthcare provided in
outpatient healthcare facilities, paid for by list of performances
the value of the item, the amount of the reimbursement of health care and regulatory limits, determined by
in Appendix 3 to this notice.
§ 6
(1) for healthcare provided by dentists, paid by
list of performances, with a point value determined in § 2.
(2) health care dental non-referred to in paragraph
1 shall be paid in accordance with the contractual arrangement between the health insurance company and
medical facilities in accordance with the regulations on price control ^ 4).
(3) the health insurance fund shall be entitled to limit the total amount of payment
medical devices so that the total amount of remuneration for health care
provided by dentists in 2008 did not exceed the amount set out in the
health insurance plan health insurance health care
provided by dentists.
§ 7
For the health care provided by health establishments
in the listed fields of medicine, paid for by the lump-sum payment or according to the
list of performances, with the point value, the amount of the reimbursement of health care and regulatory
the restrictions set out in annex 4 to this notice.
§ 8
For the health care provided by health establishments
in the fields of medicine, 921 911 and 925 by list of performances, paid by
list of performances, with the point value, the amount of the reimbursement of health care and regulatory
the restrictions set out in annex 5 to this Decree.
§ 9
For the health care provided by health establishments
in 902 by the skill list of performances, paid according to the list of performances
the value of the item, the amount of the reimbursement of health care and regulatory limits, determined by
in annex 6 to this Ordinance.
§ 10
For healthcare provided in the framework of the emergency medical services,
paid by list of performance shall be the point value in the amount of € 1.03.
§ 11
For the performances of the medical transport, paid according to the list of services, the value of
point, the amount of the reimbursement of health care and regulatory restrictions set out in annex
# 7 of this Decree.
§ 12
For healthcare provided within the medical first-aid services,
paid by list of performance shall be the point value of 0.92 €.
section 13 of the
Spa care provided by health care facilities of Spa care, and
health care in Sanatorium schools shall be paid according to the contract
arrangements between health insurance and medical facilities in accordance
with the regulations on price control ^ 4).
§ 14
For healthcare provided within the framework of emergency care in
non-medical facilities, paid for by list of performances
the value of point determined in § 2.
§ 15
This Decree shall enter into force on 1 January 2000. January 1, 2008.
Minister: MUDr. Julínek, MBA in r.
Annex 1
The value of the item, the amount of the reimbursement of health care and regulatory restrictions pursuant to § 3
And institutional care) according to § 3 (2). 1
1. Reimbursement of medical equipment in 2008 includes individually
contractually agreed lump-sum payment and folder folder.
2. Individually contractually agreed payment folder includes remuneration for
health care covered according to the classification of hospitalized
patients ^ 5) (hereinafter referred to as "the classification") into groups related to diagnosis
08021, 08022, 08023, 08041, 08042, 08043, 08181, 08182 and 08183 (
"the listed group") set out in section 3.2 and remuneration for medicinal
medicines and foods for special medical purposes (hereinafter referred to as "medicinal
preparations ") paid in 2007 on the basis of a special contract with the
health insurance under another law ^ 6). Amount and method
the payment of this health care health insurance company contractually agreed with the
the medical establishment. If the medical health insurance
the device shall agree, individually contractually agreed the payment may
include payment of other health care, than is stated in the first sentence; in
this case, this remuneration included in the remuneration referred to in point 3.1.
(Uref or Lref).
2.1 health insurance in 2008, will provide all medical
In summary, the remuneration for the facilities provided by the health care included
According to the classification in the listed groups at least 104.8%
the reimbursement of such care in 2007. Contracted by the health insurance fund shall ensure
the provision of this health care at least the same number of insured persons, as in
in 2007, with the health insurance fund shall take into account the change in 2008
the number of its policy holders compared to 2007, also in the amount of the remuneration.
2.2 health insurance in 2008, will provide all medical
equipment in summary, remuneration for reimbursable medicinal products in 2007 on the
the basis of a special contract with a health insurance company, according to another legal
předpisu6), at least in the amount of reimbursement of such care 104.8% in 2007,
While health insurance in 2008, taking into account the change in the number of its
insured persons compared to 2007.
3. The flat-rate payment folder (PUV2008), lays down the procedure for the year 2008
referred to in points 3.1 to 3.11. The reference period is the year 2007.
A flat-rate component of the remuneration is based on a basic flat-rate remuneration, which
the calculation is shown in section 3.1.
3.1 Basic lump-sum payment (PUZ2008), which includes a fixed remuneration
for inpatient care (PUZhosp2008) and the flat-rate payment for outpatient
care (PUZamb2008), referred to in section 3.3, shall be as follows:
PUZ2008 = (PUref-Uref-Lref) Cn
where:
PUref total remuneration payable to a healthcare
equipment for care provided in the reference
the period to March 31, 2008 and declared health
insurance recognised in may, after the settlement of all
regulatory measures, with the exception of the regulation on the
prescribed medicines and medical
resources. The total payment is not included
health care, which is no longer for the year 2008
nasmlouvána
Uref total remuneration for health care medical
the equipment provided in the reference period, the area declared
to March 31, 2008, and the health insurance fund recognised until 31 March 2006. 5.
2008, included according to the classification in the listed
groups
The amount of the remuneration for the calculation of Uref PUZ2008 down
as follows:
Uref = Vref * ICBref + ZUMref + ZULPref + LPref + KPref
where:
Vref number of medical facility in the reference
the period declared and health insurance company
recognised for services performed during the
hospitalizations, which are according to the classification
included in the listed groups
ICBref calculated individual price point
medical equipment, which shall be fixed as
share U2007/B2007, where:
U2007 total remuneration payable
medical devices for all
healthcare provided in the reference
the period after the settlement of all regulatory
measures, with the exception of regulation on the prescribed
medicinal products and medical devices,
reduced reimbursement for separately charged to healing
preparations and posted material,
granted in the reference period, the reported
and health insurance company recognized in the context of
in patient care, a standard amount that you
are reimbursed medicinal products pursuant to § 17 para. 7
the law and the payment of other health
care paid in Czech Crowns (KPref)
Total number of times B2007 medical facilities
declared and recognized health insurance
points for health care provided
in the reference period
ZUMref the total amount of the reimbursement of medical
the device reported and health insurance company
recognised separately posted material provided
in the reference period in connection with the performances,
made during the hospitalizations, which are
According to the classification included in the listed
groups
ZULPref the total amount of the reimbursement of medical
the device reported and health insurance company
recognised separately charged to medicinal products
granted in the reference period in the context of
with the performances, that were made during the hospitalizations, which
are according to the classification included in the listed
groups
LPref flat-rate amount shall be paid to the healing
preparations for ošetřovacím days and reported
health insurance company recognised as reference
the time period to hospitalisations, which are
According to the classification included in the listed
groups
KPref other health care paid in dollars (in addition to the
ZUMref, ZULPref and LPref) declared and health
insurance company recognized, provided the medical
the equipment during the hospitalizations, which are
According to the classification included in the listed
groups
Lref total remuneration for medicinal products reimbursable
in 2007, on the basis of a special contract with health
insurance company under another law ^ 6)
the medical facility health insurance
granted in the reference period
CN ratio rise in flat-rate remuneration, which is for the year
2008 set at 1.048
3.2 the group related to the diagnosis according to the classification of these indices
groups (hereinafter referred to as "indexes"):
-------- --------------------------------------------------------------------------------- ------------
IR-DRG ^ 5) group name Index
-------- --------------------------------------------------------------------------------- ------------
00011 HEART TRANSPLANTS and/or LUNG without CC 23.0724
00012 HEART TRANSPLANTS and/or LUNG with CC 31.7291
00013 HEART TRANSPLANTS and/or LUNG with MCC 49.8110
00021 LIVER TRANSPLANTATION without CC 22.4577
00022 LIVER TRANSPLANTATION with CC 22.6268
00023 LIVER TRANSPLANT with MCC 38.2611
00031 BONE MARROW TRANSPLANTATION without CC 18.2677
00032 BONE MARROW TRANSPLANTATION with CC 19.1717
00033 BONE MARROW TRANSPLANT with MCC 23.5596
00041 LONG-TERM MECHANICAL VENTILATION with TRACHEOSTOMIÍ without-CC 10.3796
00042 LONG-TERM MECHANICAL VENTILATION with TRACHEOSTOMIÍ with CC to 16.5360
00043 LONG-TERM MECHANICAL VENTILATION with TRACHEOSTOMIÍ with MCC 16.5360
00051 LONG-TERM MECHANICAL VENTILATION without TRACHEOSTOMY, without CC 8.0537
00052 LONG TERM MECHANICAL VENTILATION without TRACHEOSTOMY with CC 8.0537
00053 LONG TERM MECHANICAL VENTILATION without TRACHEOSTOMY with MCC 12.2795
01011 CRANIOTOMY without CC 6.3645
01012 CRANIOTOMY with CC 8.5903
01013 CRANIOTOMY with MCC 13.4239
01021 SPINAL PERFORMANCES without CC 4.0736
01022 SPINAL PERFORMANCES with CC 8.8688
01023 SPINAL PERFORMANCES with MCC 11.2103
01031 EXTRACRANIAL ARTERIES PERFORMANCES without CC 2.4735
01032 PERFORMANCES on the EXTRACRANIAL ARTERIES with CC 2.4941
01033 PERFORMANCES on the EXTRACRANIAL ARTERIES with MCC 3.2675
01041 PERFORMANCES on the CRANIAL and peripheral NERVES without CC 0.4965
01042 PERFORMANCES on the CRANIAL and peripheral NERVES with CC 0.6858
01043 PERFORMANCES on the CRANIAL and peripheral NERVES with MCC 0.9640
01051 CARPAL TUNNEL RELEASE without CC 0.1705
01052 CARPAL TUNNEL RELEASE with CC 0.2192
01053 CARPAL TUNNEL RELEASE with MCC 0.2327
01061 OTHER PERFORMANCES in DISEASES and DISORDERS of the NERVOUS SYSTEM without CC 1.4935
OTHER PERFORMANCES in 01062 diseases and DISORDERS of the NERVOUS SYSTEM with CC 2.6640
01063 OTHER PERFORMANCES in DISEASES and DISORDERS of the NERVOUS SYSTEM with MCC 8.6239
01301 disorders and SPINAL CORD INJURIES without CC 0.7136
01302 disorders and SPINAL CORD INJURIES with CC 1.1500
01303 disorders and SPINAL CORD INJURIES with MCC 2.4426
01311 MALIGNANCIES, SOME INFECTIONS and degenerative DISORDERS NERVOVÉHOSYSTÉMU 0.8321
WITHOUT CC
01312 MALIGNANCIES, SOME INFECTIONS and degenerative DISORDERS of the NERVOVÉHOSYSTÉMU with 0.9123
CC
01313 MALIGNANCIES, SOME INFECTIONS and degenerative DISORDERS of the NERVOVÉHOSYSTÉMU with 1.3147
MCC
01321 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA without CC 0.4256
01322 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA with CC 0.6226
01323 MULTIPLE SCLEROSIS and CEREBELLAR ATAXIA with MCC 0.9848
01331 TRAUMATIC INTRACRANIAL BLEEDING without CC 1.2361
01332 TRAUMATIC INTRACRANIAL HEMORRHAGE with CC 1.5223
01333 TRAUMATIC INTRACRANIAL HEMORRHAGE with MCC 2.4762
01341 STROKE with myocardial FREE CC 0.9063
01342 STROKE with myocardial with CC 0.9904
01343 STROKE with myocardial with MCC 1.3997
01351 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION without MYOCARDIAL without CC 0.7514
01352 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION without MYOCARDIAL with CC 0.8282
01353 NON-SPECIFIC STROKE and PRECEREBRÁLNÍ OCCLUSION without MYOCARDIAL with MCC 1.0579
01361 TRANSIENT ISCHAEMIC ATTACK without CC 0.5569
01362 TRANSIENT ISCHEMIC ATTACK with CC 0.6117
01363 TRANSIENT ISCHEMIC ATTACK with MCC 0.6776
01371 CRANIAL and PERIPHERAL NERVES DISORDERS without CC 0.6457
01372 DISORDERS CRANIAL and PERIPHERAL NERVES with CC 0.7490
01373 DISORDERS CRANIAL and PERIPHERAL NERVES with MCC 0.8315
01381 bacterial and TUBERCULOSIS INFECTION of the NERVOUS SYSTEM without CC 2.4394
01382 bacterial and TUBERCULOSIS INFECTION of the NERVOUS SYSTEM with CC 3.4536
01383 bacterial and TUBERCULOSIS INFECTION of the NERVOUS SYSTEM with MCC 5.0796
01391 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to VIRAL MENINGITIS BEZCC 0.8985
01392 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to VIRAL MENINGITIS with CC 1.0381
01393 NEBAKTERIÁLNÍ INFECTION of the NERVOUS SYSTEM, in ADDITION to VIRAL MENINGITIS with MCC 2.4216
01401 VIRAL MENINGITIS without CC 1.2808
01402 VIRAL MENINGITIS with CC 1.4911
01403 VIRAL MENINGITIS with MCC 1.7434
01411 NETRAUMATICKÁ DISORDER of CONSCIOUSNESS and coma without CC 0.6490
01412 NETRAUMATICKÁ DISORDER of CONSCIOUSNESS and coma with CC 0.9169
01413 NETRAUMATICKÁ DISORDER of CONSCIOUSNESS and coma with MCC 2.0175
01421 EPILEPTIC SEIZURE without CC 0.4802
01422 EPILEPTIC SEIZURE with CC 0.6091
01423 EPILEPTIC SEIZURE with MCC 0.9097
01431 MIGRAINE and other HEADACHES without CC 0.5065
01432 MIGRAINE and other HEADACHES with CC 0.6458
01433 MIGRAINE and other HEADACHES with MCC 0.7611
01441 CRANIAL and intracranial INJURIES without CC 0.8406
01442 CRANIAL and intracranial injury with CC 1.2110
01443 CRANIAL and intracranial INJURIES with MCC 3.2695
01451 CONCUSSION without CC 0.2502
01452 CONCUSSION with CC 0.2904
01453 CONCUSSION with MCC 0.4669
01461 OTHER NERVOUS SYSTEM DISORDERS without CC 0.4765
01462 OTHER NERVOUS SYSTEM DISORDERS with CC 0.6615
01463 OTHER NERVOUS SYSTEM DISORDERS with MCC 1.0660
02011 ENUKLEACE, and PERFORMANCES on the EYECUP without CC 1.0556
02012 ENUKLEACE and PERFORMANCES on the EYECUP with CC 1.5662
02013 ENUKLEACE and PERFORMANCES on the EYECUP with MCC 1.5662
EXTRAOKULÁRNÍ in ADDITION to the performances, 02021 EYEPIECE without CC 0.3875
EXTRAOKULÁRNÍ in ADDITION to the performances, 02022 EYECUP with CC 0.5844
EXTRAOKULÁRNÍ in ADDITION to the performances, 02023 EYECUP with MCC 0.6275
02031 INTRAOCULAR LENSES, EXCEPT without the CC 0.7068
02032 INTRAOCULAR procedures, in ADDITION to LENSES with CC 0.8490
in ADDITION to the performances, 02033 INTRAOCULAR LENSES with MCC 0.9424
02041 PERFORMANCES on the LENS with or without VITREKTOMIE without-CC 0.5243
02042 the PERFORMANCES on the LENS with or without VITREKTOMIE with CC 0.5719
02043 PERFORMANCES on the LENS with or without VITREKTOMIE with the MCC 0.5719
02301 ACUTE and SERIOUS EYE INFECTION without CC 0.5036
02302 acute and SERIOUS EYE INFECTION with CC 0.5837
acute and SEVERE 02303 EYE INFECTION with MCC 1.3356
02311 NEUROLOGICAL and vascular EYE DISORDERS without CC 0.4753
02312 neurological and VASCULAR DISORDERS of the EYE with CC 0.6930
02313 NEUROLOGICAL and vascular EYE DISORDERS with MCC 0.8829
02321 OTHER EYE DISORDERS without CC 0.2992
02322 OTHER EYE DISORDERS with CC 0.3664
02323 OTHER EYE DISORDERS with MCC 0.4516
03011 GREAT PERFORMANCES on the larynx and TRACHEA without CC 3.6595
03012 GREAT PERFORMANCES on the larynx and TRACHEA with CC 6.6018
03013 GREAT PERFORMANCES on the larynx and TRACHEA with MCC 8.4143
03021 OTHER BIG PERFORMANCES on his head and neck without CC 3.0742
03022 OTHER BIG PERFORMANCES on the head and neck with CC 3.5674
OTHER LARGE 03023 PERFORMANCES on the head and neck with MCC 6.4343
03031 PERFORMANCES on the FACIAL bones, in ADDITION to LARGE POWER OUTPUTS on the HEAD and neck without CC 1.7449
03032 PERFORMANCES on the FACIAL bones, in ADDITION to LARGE POWER OUTPUTS on the HEAD and neck with CC 2.0582
03033 PERFORMANCES on the FACIAL bones, in ADDITION to LARGE POWER OUTPUTS on the HEAD and neck with MCC 4.4506
03041 PERFORMANCES on the MOUTH without CC 0.8561
03042 PERFORMANCES on mouth with CC 0.8561
03043 PERFORMANCES on mouth with MCC 1.0999
03051 PERFORMANCES on the CAVITIES and MASTOIDU without-CC 1.4393
03052 PERFORMANCES on the CAVITIES and MASTOIDU with CC to 1.4716
03053 PERFORMANCES on the CAVITIES and MASTOIDU with MCC 1.9900
03061 PERFORMANCES on SALIVARY GLAND without CC 1.0647
03062 PERFORMANCES on SALIVARY GLAND with CC 1.3239
PERFORMANCES on the SALIVARY GLAND 03063 with MCC 1.3773
03071 AXLE of cleft lip and PALATE without CC 1.7970
03072 AXLE of cleft lip and PALATE with CC 1.7970
03073 AXLE of cleft lip and PALATE with MCC 1.7970
03081 PERFORMANCES on the CERVICAL and nasal ALMONDS without CC 0.4975
03082 PERFORMANCES on the CERVICAL and nasal ALMONDS with CC 0.6572
03083 PERFORMANCES on the CERVICAL and nasal ALMONDS with MCC 1.0657
03091 OTHER PERFORMANCES in DISORDERS and DISEASES of ears, nose, mouth and throat without CC 0.7784
03092 OTHER PERFORMANCES with FAULTS and DISEASES of the ears, nose, mouth and throat with CC 0.8953
03093 OTHER PERFORMANCES in DISORDERS and DISEASES of ears, nose, mouth and throat with MCC 1.2975
03301 MALIGNANT DISEASE of ear, nose, mouth and throat without CC 0.8106
03302 MALIGNANT DISEASE of the ear, nose, mouth and throat with CC 0.8465
03303 MALIGNANT DISEASE ear, nose, mouth and throat with MCC 0.8465
03311 BALANCE DISORDERS without CC 0.5348
03312 BALANCE DISORDERS with CC 0.5892
03313 BALANCE DISORDERS with MCC 0.7135
without CC 0.3438 03321 EPISTAXIS
03322 EPISTAXIS with CC 0.4353
03323 EPISTAXIS with MCC 0.5223
03331 EPIGLOTTITIS, OTITIS MEDIA, infection of the upper respiratory tract, LARYNGOTRACHEITIS without 0.3300
CC
03332 EPIGLOTTITIS, OTITIS MEDIA, infection of the upper respiratory tract, LARYNGOTRACHEITIS with 0.4540
CC
03333 EPIGLOTTITIS, OTITIS MEDIA, infection of the upper respiratory tract, LARYNGOTRACHEITIS with 0.5898
MCC
DISEASES of the TEETH and mouth 03341 without CC 0.5060
03342 DISEASES of the TEETH and mouth with CC 0.5659
DISEASES of the TEETH and mouth 03343 with MCC 0.7616
03351 OTHER DISORDERS of the ears, nose, mouth and throat without CC 0.4165
03352 OTHER DISORDERS of the ears, nose, mouth and throat with CC 0.5351
OTHER DISORDERS 03353 ears, nose, mouth and throat with MCC 0.5427
04011 LARGE THORACIC PERFORMANCES without CC 4.8107
04012 LARGE THORACIC PERFORMANCES with CC 5.4528
04013 BIG CHEST with MCC 8.4785
04021 SMALLER CHEST PERFORMANCES without CC 3.2354
04022 SMALLER CHEST with CC 3.2354
04023 SMALLER CHEST with MCC 4.6582
04031 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY SYSTEM without CC 1.6252
04032 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY SYSTEM with CC 2.2363
04033 OTHER PERFORMANCES in DISORDERS and DISEASES of the RESPIRATORY SYSTEM with MCC 3.4523
04301 CYSTIC FIBROSIS without CC 2.4258
04302 CYSTIC FIBROSIS with CC 2.4258
04303 CYSTIC FIBROSIS with MCC 2.7644
04310 RESPIRATORY FAILURE 2.8649
04321 PULMONARY EMBOLISM without CC 1.1455
04322 PULMONARY EMBOLISM with CC 1.1961
04323 PULMONARY EMBOLISM with MCC 1.3398
04331 SEVERE TRAUMA to the CHEST without CC 0.5520
04332 SEVERE TRAUMA to CHEST with CC 0.8659
04333 SEVERE TRAUMA to CHEST with MCC 1.7009
04341 MALIGNANT DISEASE RESPIRATORY SYSTEM without CC 0.8615
04342 MALIGNANT DISEASE of the RESPIRATORY SYSTEM with CC 0.8615
04343 MALIGNANT DISEASE RESPIRATORY SYSTEM with MCC 1.1205
04351 RESPIRATORY SYSTEM infections and inflammations without CC 1.0908
04352 RESPIRATORY SYSTEM infections and inflammations with CC 1.1928
04353 RESPIRATORY SYSTEM infections and inflammations with MCC 2.3344
04361 SIMPLE pneumonia and WHOOPING COUGH without CC 0.7420
04362 SIMPLE pneumonia and WHOOPING COUGH with CC 0.9430
04363 SIMPLE pneumonia and WHOOPING COUGH with MCC 1.3050
04371 CHRONIC OBSTRUCTIVE PULMONARY DISEASE without CC 0.6663
04372 CHRONIC OBSTRUCTIVE PULMONARY disease with CC 0.7691
04373 CHRONIC OBSTRUCTIVE PULMONARY disease with MCC 1.0133
asthma and BRONCHIOLITIS 04381 without CC 0.4676
04382 asthma and BRONCHIOLITIS with CC 0.6338
04383 asthma and BRONCHIOLITIS with MCC 0.8267
04391 INTERSTITIAL LUNG DISEASE without CC 1.0433
04392 INTERSTITIAL LUNG DISEASE with CC 1.0974
04393 INTERSTITIAL LUNG DISEASE with MCC 1.6177
04401 PNEUMOTHORAX without CC PLEURÁNÍ the EFFUSION and 1.0550
04402 PNEUMOTHORAX and PLEURÁNÍ EFFUSION with CC 1.2511
04403 PNEUMOTHORAX and PLEURÁNÍ EFFUSION with MCC 1.7318
04411 signs, symptoms and other RESPIRATORY SYSTEM DIAGNOSIS without CC 0.4874
04412 signs, symptoms and other RESPIRATORY SYSTEM DIAGNOSIS with CC 0.6806
04413 signs, symptoms and other RESPIRATORY SYSTEM DIAGNOSIS with MCC 0.8956
05011 CARDIAC DEFIBRILLATOR IMPLANT and to SUPPORT HEART FUNCTION without CC 52.5905
05012 CARDIAC DEFIBRILLATOR IMPLANT and to SUPPORT HEART FUNCTION with CC 54.0460
05013 CARDIAC DEFIBRILLATOR IMPLANT and to SUPPORT HEART FUNCTION with MCC 56.6298
05021 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP without CC 16.7875
05022 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with CC 22.0351
05023 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with MCC 22.2832
the operations and PROCEDURES for 05031 CONGENITAL HEART DEFECTS without CC 10.1476
05032 operations and PROCEDURES for CONGENITAL HEART DISEASE with CC 11.1589
05033 operations and PROCEDURES for CONGENITAL HEART DEFECTS with MCC 18.1966
05041 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION without CC 14.5375
05042 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION with CC 16.3142
05043 PERFORMANCES on HEART FLAP without cardiac catheterization with MCC 18.6424
05051 CORONARY BYPASS SURGERY with HEART-CATH LAB without CC 12.0895
05052 CORONARY BYPASS SURGERY with HEART-CATH LAB with CC 14.0417
05053 CORONARY BYPASS SURGERY with HEART-CATH LAB with MCC 15.0073
05061 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION without CC 10.0195
05062 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with CC 10.4284
05063 CORONARY BYPASS SURGERY without cardiac catheterization with MCC 12.5552
PERMANENT PACEMAKER IMPLANTATION in 05070 acute myocardial infarction, 11.9405 FAILURE
HEART OR SHOCK
OTHER PERFORMANCES of the CARDIOTHORACIC 05081 without CC 5.9993
05082 OTHER CARDIOTHORACIC PERFORMANCES with CC 5.9993
05083 OTHER CARDIOTHORACIC PERFORMANCES with MCC 5.9993
05091 LARGE ABDOMINAL VASCULAR PERFORMANCE without CC 6.6534
05092 LARGE ABDOMINAL VASCULAR PERFORMANCE with CC 8.1396
05093 LARGE ABDOMINAL VASCULAR PERFORMANCE with MCC 9.5806
05101 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with ACUTE MYOCARDIAL INFARCTION without CC 6.9680
05102 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with ACUTE MYOCARDIAL INFARCTION with CC 7.0606
05103 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL INFARCTION with MCC 8.0973
IMPLANTATION of PERMANENT PACEMAKER 05111 without acute myocardial infarction, 6.5566 FAILURE
HEART OR SHOCK WITHOUT CC
IMPLANTATION of PERMANENT PACEMAKER 05112 without acute myocardial infarction, 6.5566 FAILURE
HEART OR SHOCK WITH CC
IMPLANTATION of PERMANENT PACEMAKER 05113 without acute myocardial infarction, 7.2851 FAILURE
HEART OR SHOCK WITH MCC
LARGE THORACIC VASCULAR 05121 PERFORMANCES without CC 6.5536
LARGE THORACIC VASCULAR 05122 PERFORMANCES with CC 6.5536
05123 LARGE THORACIC VASCULAR PERFORMANCE with MCC 10.3806
05131 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL INFARCTION BEZCC 5.7124
05132 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL INFARCTION with CC 5.8581
05133 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL INFARCTION with MCC 6.4009
OTHER VASCULAR 05141 PERFORMANCES without CC 4.3372
OTHER VASCULAR 05142 PERFORMANCES with CC 4.4854
OTHER VASCULAR 05143 PERFORMANCES with MCC 6.3226
05151 AMPUTATION DUE to a FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER LIMBS and fingers at the foot of 2.3171
WITHOUT CC
05152 AMPUTATION DUE to a FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER LIMBS and fingers at the foot with 2.7170
CC
05153 AMPUTATION DUE to a FAILURE of the CIRCULATORY SYSTEM, in ADDITION to the UPPER LIMBS and fingers at the foot with 3.3721
MCC
pacemaker and DEFIBRILLATOR 05161 REPLACEMENT without CC 4.7336
pacemaker and DEFIBRILLATOR REPLACEMENT 05162 with CC 4.7336
pacemaker and DEFIBRILLATOR 05163 REPLACEMENT with MCC 6.3416
05171 AMPUTATION of UPPER LIMB and TOE on leg DUE to a FAULT of the CIRCULATORY SYSTÉMUBEZ CC 1.3688
05172 AMPUTATION of UPPER LIMB and TOE on leg DUE to a FAULT of the CIRCULATORY SYSTÉMUS CC 1.9549
05173 AMPUTATION of UPPER LIMB and TOE on leg DUE to a FAULT of the CIRCULATORY SYSTÉMUS MCC 2.9111
CONTROL pacemaker and DEFIBRILLATOR 05181, EXCEPT for REPLACEMENT of EQUIPMENT BEZCC 1.0108
CONTROL pacemaker and DEFIBRILLATOR 05182, EXCEPT for REPLACEMENT of EQUIPMENT with CC 1.6628
CONTROL pacemaker and DEFIBRILLATOR 05183, EXCEPT for REPLACEMENT of equipment with MCC 1.6628
05191 LIGATURE and STRIPPING the VESSELS without CC 0.6642
05192 LIGATURE and STRIPPING the VESSELS with CC 0.7653
05193 LIGATURE and STRIPPING the VESSELS with MCC 0.7653
05201 OTHER PERFORMANCES in DISEASES and DISORDERS of the CIRCULATORY SYSTEM without CC 1.5421
05202 OTHER PERFORMANCES in DISEASES and DISORDERS of the CIRCULATORY SYSTEM with CC 2.2460
05203 OTHER PERFORMANCES in DISEASES and DISORDERS of the CIRCULATORY SYSTEM with MCC 5.6663
05301 CARDIAC CATHETERIZATION DURING ACUTE MYOCARDIAL INFARCTION without CC 1.6476
05302 CARDIAC CATHETERIZATION in ACUTE MYOCARDIAL INFARCTION with CC 1.7366
05303 CARDIAC CATHETERIZATION in ACUTE MYOCARDIAL INFARCTION with MCC 2.3639
05311 CARDIAC CATHETERIZATION in the ISCHEMIC HEART without CC 1.0102
05312 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with CC 1.1061
05313 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with MCC 1.2632
05321 CARDIAC CATHETERIZATION when OTHER CIRCULATORY SYSTEM DISORDERS without CC 1.4642
05322 CARDIAC CATHETERIZATION when OTHER DISORDERS of the CIRCULATORY SYSTEM with CC 1.7087
05323 CARDIAC CATHETERIZATION when OTHER DISORDERS of the CIRCULATORY SYSTEM with MCC 2.6629
05331 ACUTE MYOCARDIAL INFARCTION without CC 0.6724
05332 ACUTE MYOCARDIAL INFARCTION with CC 0.9479
05333 ACUTE MYOCARDIAL INFARCTION with MCC 1.2698
05341 acute and subacute ENDOCARDITIS without CC 2.4260
acute and subacute ENDOCARDITIS 05342 with CC 2.5894
acute and subacute ENDOCARDITIS 05343 with MCC 8.4743
05351 HEART FAILURE without CC 0.7410
05352 HEART FAILURE with CC 0.8282
05353 HEART FAILURE with MCC 1.1121
05361 DEEP VEIN THROMBOSIS without CC 0.6206
05362 DEEP VENOUS THROMBOSIS with CC 0.7194
05363 DEEP VENOUS THROMBOSIS with MCC 0.8818
05371 UNEXPLAINED CARDIAC ARREST without CC 1.0161
05372 UNEXPLAINED CARDIAC ARREST with CC 1.0161
05373 UNEXPLAINED CARDIAC ARREST with MCC 2.1377
05381 PERIPHERAL and other vascular disorders without CC 0.7406
05382 PERIPHERAL and other vascular disorders with CC 0.8750
05383 PERIPHERAL and other vascular disorders with MCC 0.9188
05391 ATHEROSCLEROSIS without CC 0.5251
05392 ATHEROSCLEROSIS with CC 0.6371
05393 ATHEROSCLEROSIS with MCC 0.8796
05401 HYPERTENSION without CC 0.4471
05402 HYPERTENSION with CC 0.5140
05403 HYPERTENSION with MCC 0.6123
05411 VALVULAR and CONGENITAL HEART DISORDERS without CC 0.5000
05412 VALVULAR and CONGENITAL HEART DISORDERS with CC 0.7038
05413 CONGENITAL HEART and VALVULAR DISORDERS with MCC 1.1392
05421 CARDIAC ARRHYTHMIAS and CONDUCTION DISORDERS without CC 0.4945
05422 CARDIAC ARRHYTHMIA and CONDUCTION DISORDERS with CC 0.6543
05423 CARDIAC ARRHYTHMIAS and CONDUCTION DISORDERS with MCC 0.9152
05431 ANGINA and chest pain without CC 0.4569
05432 ANGINA and chest pain with CC 0.5615
05433 ANGINA and chest pain with MCC 0.7229
05441 syncope and COLLAPSE without CC 0.3978
05442 syncope and COLLAPSE with CC 0.5342
05443 syncope and COLLAPSE with MCC 0.6674
05451 CARDIOMYOPATHY without CC 0.4672
05452 CARDIOMYOPATHY with CC 0.6910
05453 CARDIOMYOPATHY with MCC 0.9185
05461 failures, reactions and complications of HEART or VASCULAR DEVICE 0.5407
OR PERFORMANCE WITHOUT CC
05462 failures, reactions and complications of HEART or VASCULAR INSTRUMENTS or PERFORMANCE with CC 0.6021
05463 failures, reactions and complications of HEART or VASCULAR INSTRUMENTS or PERFORMANCE with MCC 0.6021
OTHER DISORDERS of the CIRCULATORY SYSTEM 05471 without CC 0.5678
OTHER DISORDERS of the CIRCULATORY SYSTEM 05472 with CC 0.7468
OTHER DISORDERS of the CIRCULATORY SYSTEM 05473 with MCC 1.0016
06011 BIG PERFORMANCES on the THICK and THIN INTESTINE without CC 3.6731
GREAT PERFORMANCES on the THICK 06012 and THIN INTESTINE with CC 4.2191
06013 BIG PERFORMANCES on the THICK and THIN INTESTINE with MCC 5.6110
06021 BIG PERFORMANCES on the stomach, ESOPHAGUS and duodenum without CC 3.6624
06022 GREAT PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with CC 4.8275
06023 BIG PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with MCC 6.7506
06031 LESS PERFORMANCES on the THICK and THIN INTESTINE without CC 1.7879
06032 LESS PERFORMANCES on the THICK and THIN INTESTINE with CC 2.5501
06033 LESS PERFORMANCES on the THICK and THIN INTESTINE with MCC 3.4926
06041 RELEASE of TISSUE of PERITONEUM without CC 1.3429
06042 RELEASE of TISSUE of PERITONEUM with CC 1.6255
06043 RELEASE of TISSUE of PERITONEUM with MCC 2.0839
06051 PERFORMANCES on APENDIXU without-CC 1.0370
06052 PERFORMANCES at APENDIXU with CC to 1.2758
06053 PERFORMANCES on APENDIXU with MCC 1.8180
06061 LAPAROSCOPIC INGUINAL, femoral PERFORMANCE, UMBILICAL or EPIGASTRIC HERNIA 1.5392
WITHOUT CC
06062 LAPAROSCOPIC INGUINAL, femoral PERFORMANCE, UMBILICAL or EPIGASTRIC HERNIA 1.6371
WITH CC
06063 LAPAROSCOPIC INGUINAL, femoral PERFORMANCE, UMBILICAL or EPIGASTRIC HERNIA 1.7226
WITH MCC
06071 LESS PERFORMANCES on the stomach, ESOPHAGUS and duodenum without CC 3.0442
06072 LESS PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with CC 3.3392
06073 LESS PERFORMANCES on the STOMACH, esophageal and duodenal ulcers with MCC 4.2782
LAPAROTOMICKÉ PERFORMANCE 06081 INGUINAL, Femoral, UMBILICAL or EPIGASTRIC HERNIA 0.7236
WITHOUT CC
LAPAROTOMICKÉ PERFORMANCE 06082 INGUINAL, Femoral, UMBILICAL or EPIGASTRIC HERNIA 1.0194
WITH CC
LAPAROTOMICKÉ PERFORMANCE 06083 INGUINAL, Femoral, UMBILICAL or EPIGASTRIC HERNIA 1.3567
WITH MCC
06091 anal and OSTOMY PERFORMANCES without CC 0.6235
06092 anal and OSTOMY PERFORMANCES with CC 0.7519
06093 anal and OSTOMY PERFORMANCES with MCC 0.8770
06101 OTHER PERFORMANCES in DISORDERS and DISEASES of the DIGESTIVE SYSTEM without CC 1.0202
06102 OTHER PERFORMANCES in DISORDERS and DISEASES of the DIGESTIVE SYSTEM with CC 2.1232
06103 OTHER PERFORMANCES in DISORDERS and DISEASES of the DIGESTIVE SYSTEM with MCC 3.0604
06111 PERFORMANCES on APENDIXU when the MAIN COMPLICATING DIAGNOSIS without CC 1.4644
06112 PERFORMANCES on APENDIXU when the MAIN COMPLICATING DIAGNOSIS with CC 1.8829
06113 PERFORMANCES on APENDIXU when COMPLICATING the MAIN DIAGNOSIS with MCC 2.5313
MALIGNANT DISEASES of the DIGESTIVE SYSTEM 06301 without CC 0.5194
MALIGNANT DISEASES of the DIGESTIVE SYSTEM 06302 with CC 0.5713
06303 MALIGNANT DISEASE of the DIGESTIVE SYSTEM with MCC 0.9041
06311 peptic ulcer and GASTRITIS without CC 0.4338
06312 peptic ulcer and GASTRITIS with CC 0.7049
06313 peptic ulcer and GASTRITIS with MCC 0.9936
06321 ESOPHAGEAL DISORDERS without CC 0.4639
06322 ESOPHAGEAL DISORDERS with CC 0.6652
06323 ESOPHAGEAL DISORDERS with MCC 0.9543
06331 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASES of the INTESTINE without CC 0.5172
06332 DIVERTICULITIS, DIVERTICULOSIS and INFLAMMATORY DISEASE of the BOWEL with CC 0.6618
06333 diverticulosis and diverticulitis, an INFLAMMATORY DISEASE of the intestines with MCC 1.0051
06341 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM without CC 0.2081
06342 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM with CC 0.2849
06343 VASCULAR INSUFFICIENCY, GASTROINTESTINAL SYSTEM with MCC 1.7401
06351 OBSTRUCTION of the GASTROINTESTINAL SYSTEM without CC 0.4627
OBSTRUCTION of the GASTROINTESTINAL SYSTEM 06352 with CC 0.6720
06353 OBSTRUCTION of the GASTROINTESTINAL SYSTEM with MCC 0.9796
SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06361 without CC 0.9576
SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06362 with CC 1.3744
SERIOUS INFECTIONS of the GASTROINTESTINAL SYSTEM 06363 with MCC 3.4782
06371 OTHER GASTROENTERITIS and ABDOMINAL PAIN without CC 0.2976
06372 OTHER GASTROENTERITIS and ABDOMINAL PAIN with CC 0.4062
06373 OTHER GASTROENTERITIS and ABDOMINAL PAIN with MCC 0.5476
OTHER DISORDERS of the DIGESTIVE SYSTEM 06381 without CC 0.3462
06382 OTHER DISORDERS of the DIGESTIVE SYSTEM with CC 0.5037
06383 OTHER DISORDERS of the DIGESTIVE SYSTEM with MCC 0.7064
07011 PERFORMANCES on the pancreas, the liver and the CLUTCH without CC 5.0070
07012 PERFORMANCES on the pancreas, the liver and the clutch-CC 6.4394
07013 PERFORMANCES on the pancreas, LIVER and couplings with MCC 9.8310
07021 GREAT PERFORMANCES on the BILIARY TRACT without CC 3.5489
07022 GREAT PERFORMANCES on the BILIARY TRACT with CC 3.9966
07023 GREAT PERFORMANCES on the BILIARY TRACT with MCC 5.3700
in ADDITION to LAPAROSCOPIC cholecystectomy 07031 without CC 1.6134
in ADDITION to LAPAROSCOPIC cholecystectomy 07032 with CC 2.1594
in ADDITION to LAPAROSCOPIC cholecystectomy 07033 with MCC 2.9560
07041 LAPAROSCOPIC CHOLECYSTECTOMY without CC 1.6302
07042 LAPAROSCOPIC CHOLECYSTECTOMY with CC 1.8555
07043 LAPAROSCOPIC CHOLECYSTECTOMY with MCC 2.2424
07051 OTHER PERFORMANCES in DISORDERS and DISEASES of HEPATOBILIÁRNÍHO system and PANCREATIC 2.3623
WITHOUT CC
07052 OTHER PERFORMANCES in DISORDERS and DISEASES of the PANCREAS with HEPATOBILIÁRNÍHO system and 3.2639
CC
07053 OTHER PERFORMANCES in DISORDERS and DISEASES of the PANCREAS with HEPATOBILIÁRNÍHO system and 6.9960
MCC
CIRRHOSIS and ALCOHOLIC HEPATITIS 07301 without CC 0.6742
07302 CIRRHOSIS and ALCOHOLIC HEPATITIS with CC 0.8163
07303 CIRRHOSIS and ALCOHOLIC HEPATITIS with MCC 1.1692
07311 MALIGNANCIES HEPATOBILIÁRNÍHO SYSTEM and pancreas without CC 0.7157
07312 HEPATOBILIÁRNÍHO system and MALIGNANT DISEASE of the PANCREAS with CC 0.7541
07313 MALIGNANCIES HEPATOBILIÁRNÍHO SYSTEM and pancreas with MCC 1.0596
07321 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE without CC 0.7580
07322 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE with CC 1.0448
07323 PANCREATIC DISORDERS, in ADDITION to the MALIGNANT DISEASE with MCC 1.7183
07331 liver disorders, in ADDITION to CIRRHOSIS and alcoholic HEPATITIS, MALIGNANT NON-CC 0.5102
07332 liver disorders, in ADDITION to CIRRHOSIS and alcoholic HEPATITIS, MALIGNANT with CC 0.7458
07333 liver disorders, in ADDITION to CIRRHOSIS and alcoholic HEPATITIS, MALIGNANT with MCC 1.0898
OTHER DISORDERS of the BILIARY TRACT 07341 without CC 0.5747
OTHER DISORDERS of the BILIARY TRACT 07342 with CC 0.8173
07343 OTHER DISORDERS of the BILE DUCTS with MCC 1.1038
the FUSION of the SPINE when 08011 DEFORMITÁCH and SCOLIOSIS without CC 11.5900
the FUSION of the SPINE when 08012 DEFORMITÁCH and SCOLIOSIS with CC 11.5900
the FUSION of the SPINE when 08013 DEFORMITÁCH and SCOLIOSIS with MCC 11.5900
08021 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS of the LOWER LIMBS without CC 6.1211
08022 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS of the LOWER LIMBS SCC 7.2069
08023 BILATERAL and multiple GREAT PERFORMANCES on the JOINTS of the LOWER LIMBS SMCC 12.2256
SPINAL FUSION 08031, not for the DEFORMITY without CC 6.9862
08032 FUSION spine, NOT for DEFORMITY with CC 8.7586
08033 FUSION of the SPINE, not for DEFORMITY with MCC 10.5248
08041 PERFORM REPLANTACE of the LOWER LIMBS and the JOINTS without CC 4.4515
08042 PERFORM REPLANTACE of the LOWER LIMBS and joints with CC 4.4617
08043 PERFORM REPLANTACE of the LOWER LIMBS and joints with MCC 5.0558
08051 RECONSTRUCTION PERFORMANCE of CRANIAL and FACIAL BONES without CC 2.9472
08052 RECONSTRUCTION PERFORMANCE of CRANIAL and FACIAL BONES with CC 2.9472
08053 RECONSTRUCTION PERFORMANCE of CRANIAL and FACIAL BONES with MCC 8.2626
08061 BIG PERFORMANCES REPLANTACE the UPPER LIMBS and the JOINTS without CC 3.3633
08062 BIG PERFORMANCES REPLANTACE the UPPER LIMBS and the joints with CC 5.1291
08063 PERFORM REPLANTACE of the UPPER EXTREMITIES and joints with MCC 9.9228
08071 AMPUTATION in MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS without CC 2.7203
08072 AMPUTATION in MUSCULO-SKELETAL DISORDERS, connective tissue and the SCC 2.7203
08073 AMPUTATION in MUSCULO-SKELETAL DISORDERS, connective tissue and SMCC 4.9478
08081 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the LARGE JOINTS without CC REPLANTACE 2.6233
08082 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE of LARGE JOINTS SCC 3.1903
08083 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the LARGE JOINTS SMCC REPLANTACE 3.9092
08091 SKIN GRAFTING or TISSUE for MUSCULOSKELETAL DISORDERS SYSTÉMUNEBO 0.6543
CONNECTIVE TISSUE IN ADDITION TO HAND WITHOUT CC
08092 SKIN GRAFTING or TISSUE for MUSCULOSKELETAL DISORDERS SYSTÉMUNEBO 1.1209
CONNECTIVE TISSUE IN ADDITION TO HAND WITH CC
08093 SKIN GRAFTING or TISSUE for MUSCULOSKELETAL DISORDERS SYSTÉMUNEBO 2.0521
CONNECTIVE TISSUE IN ADDITION TO HAND WITH MCC
08101 PERFORMANCES on the back and neck, in ADDITION to the FUSION of the SPINE without CC 2.0461
08102 PERFORMANCES on the back and neck, in ADDITION to the FUSION of the SPINE with CC 2.7290
08103 PERFORMANCES on the back and neck, in ADDITION to the FUSION of the SPINE with MCC 3.6808
08111 PERFORMANCES on the LOWER LEG and knee, HOCK, in ADDITION to the FOOT without CC 1.4430
08112 PERFORMANCES on the LOWER LEG and knee, HOCK, in addition to the FOOT with CC 1.8277
08113 PERFORMANCES on the LOWER LEG and knee, HOCK, in addition to the FOOT with MCC 2.3975
08121 REMOVAL of the INTERNAL FIXATION DEVICES without CC 0.4701
REMOVAL of INTERNAL FIXATION DEVICES 08122 with CC 0.5074
REMOVAL of INTERNAL FIXATION DEVICES 08123 with MCC 0.6439
08131 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM without CC 0.8485
08132 LOCAL RESECTION on the MUSCULOSKELETAL SYSTEM with CC 1.1269
08133 LOCAL RESECTION on the MUSCULOSKELETAL system with MCC 2.0512
08141 PERFORMANCES on FOOT without CC 0.5973
08142 PERFORMANCES on FOOT with CC 0.6442
08143 PERFORMANCES on FOOT with MCC 0.6442
08151 PERFORMANCES on the UPPER LIMBS without CC 0.8746
08152 PERFORMANCES on the UPPER EXTREMITIES with CC 1.2338
08153 PERFORMANCES on the UPPER EXTREMITY with MCC 1.8023
08161 PERFORMANCES on SOFT TISSUE without CC 0.6578
08162 PERFORMANCES on SOFT TISSUE with CC 0.8631
08163 PERFORMANCE on SOFT TISSUE with MCC 1.4940
the PERFORMANCES of the OTHER DISORDERS 08171 and DISEASES of the MUSCULOSKELETAL system and CONNECTIVE 0.9187
TISSUE WITHOUT CC
08172 OTHER PERFORMANCES in DISORDERS and DISEASES of the MUSCULOSKELETAL system and CONNECTIVE 1.2544
TISSUE WITH CC
08173 OTHER PERFORMANCES in DISORDERS and DISEASES of the MUSCULOSKELETAL system and CONNECTIVE 2.3116
TISSUE WITH MCC
08181 GREAT PERFORMANCES on the KNEE JOINT without CC 5.8446
08182 GREAT PERFORMANCES on the KNEE JOINT with CC 5.8446
08183 BIG PERFORMANCE on the KNEE JOINT with MCC 6.2074
08191 ARTHROSCOPY without CC 0.7043
08192 ARTHROSCOPY with CC 0.7188
08193 ARTHROSCOPY with MCC 0.8781
08301 FRACTURES of the FEMUR without CC 0.6936
08302 FRACTURES of the FEMUR with CC 0.8794
08303 FRACTURES of the FEMUR with MCC 1.0071
08311 FRACTURE DISLOCATION of the HIP, pelvis, or without CC 0.6422
08312 FRACTURE DISLOCATION of the HIP, pelvis, or with CC 0.7791
08313 FRACTURE DISLOCATION of the HIP, pelvis, or with MCC 0.8492
08321 FRACTURE or DISLOCATION, in ADDITION to the FEMUR and pelvis without CC 0.3808
08322 FRACTURE or DISLOCATION, in ADDITION to the FEMUR and pelvis with CC 0.5381
08323 FRACTURE or DISLOCATION, in ADDITION to the FEMUR and pelvis with MCC 0.7977
08331 MALIGNANT DISEASE MUSCULOSKELETAL and CONNECTIVE TISSUE DISORDERS, pathological 0.7854
FRACTURES WITHOUT CC
08332 MALIGNANT DISEASE MUSCULOSKELETAL and CONNECTIVE TISSUE DISORDERS, pathological 0.8351
FRACTURES WITH CC
08333 MALIGNANT DISEASE of the MUSCULOSKELETAL system and CONNECTIVE TISSUE, pathological 1.5143
FRACTURES WITH MCC
08341 OSTEOMYELITIS without CC 0.8291
08342 OSTEOMYELITIS with CC 0.8291
08343 OSTEOMYELITIS with MCC 1.4735
08351 SEPTIC ARTHRITIS without CC 0.8493
08352 SEPTIC ARTHRITIS with CC 1.4638
08353 SEPTIC ARTHRITIS with MCC 3.1266
CONNECTIVE TISSUE DISORDERS without 08361 CC 0.8386
08362 DISORDERS of CONNECTIVE TISSUE with CC 0.9048
08363 CONNECTIVE TISSUE DISORDERS with MCC 1.4629
08371 CONSERVATIVE TREATMENT of BACK PROBLEMS without CC 0.5933
08372 CONSERVATIVE TREATMENT of BACK PROBLEMS with CC 0.6885
08373 CONSERVATIVE TREATMENT of BACK PROBLEMS with MCC 0.7602
08381 OTHER DISEASES of bones and joints without CC 0.6199
08382 OTHER DISEASES of bones and joints with CC 0.7428
08383 OTHER DISEASES of bones and joints with MCC 0.8550
08391 failures, reactions and complications ORTHOPAEDIC APPARATUS or PERFORMANCE without CC 0.7127
08392 failures, reactions and complications ORTHOPAEDIC APPARATUS or PERFORMANCE with CC 1.0408
08393 failures, reactions and complications ORTHOPAEDIC APPARATUS or performance with MCC 1.1545
08401 MUSCULOSKELETAL SYMPTOMS, symptoms, sprains and MINOR INFLAMMATORY DISEASE 0.4304
WITHOUT CC
08402 MUSCULOSKELETAL SYMPTOMS, symptoms, sprains and MINOR INFLAMMATORY diseases with 0.5987
CC
08403 MUSCULOSKELETAL SYMPTOMS, symptoms, sprains and MINOR INFLAMMATORY diseases with 0.9768
MCC
08411 OTHER MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS without CC 0.4172
08412 OTHER MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS with CC 0.5994
08413 OTHER MUSCULO-SKELETAL DISORDERS, and CONNECTIVE TISSUE DISORDERS with MCC 0.8202
09011 SKIN GRAFT and/or DEBRIDEMENT without CC 0.8104
09012 SKIN GRAFT and/or DEBRIDEMENT with CC 1.3868
09013 SKIN GRAFT and/or DEBRIDEMENT with MCC 2.6426
09021 PERFORMANCES on the BREASTS without CC 0.8715
09022 PERFORMANCES on the BREASTS with CC 1.0977
09023 PERFORMANCES on the BREASTS with MCC 1.5319
the PERFORMANCES of the OTHER DISORDERS 09031 and DISEASES of the skin, subcutaneous tissue and BREAST without CC 0.4914
the PERFORMANCES of the OTHER DISORDERS 09032 and DISEASES of the skin, subcutaneous tissue and BREAST with CC 0.8577
09033 OTHER PERFORMANCES in DISORDERS and DISEASES of the skin, subcutaneous tissue and BREAST with MCC 1.2532
09301 SERIOUS SKIN DISORDERS without CC 0.7910
09302 SERIOUS SKIN DISORDERS with CC 0.9569
09303 SERIOUS SKIN DISORDERS with MCC 1.0804
MALIGNANT BREAST DISEASE without 09311 CC 0.7240
MALIGNANT BREAST DISEASE 09312 with CC 0.7240
MALIGNANT BREAST DISEASE 09313 with MCC 0.8668
09321 FLEGMÓNA without CC 0.5599
09322 FLEGMÓNA with CC to 0.7935
09323 FLEGMÓNA with MCC 0.9861
09331 INJURY to the skin, subcutaneous tissue and BREAST without CC 0.2672
09332 INJURY to the skin, subcutaneous tissue and BREAST with CC 0.3840
09333 INJURIES of the SKIN, subcutaneous tissue and BREAST with MCC 0.5430
09341 OTHER SKIN DISORDERS and breast disorders without CC 0.4746
09342 OTHER SKIN DISORDERS and BREAST DISORDERS with CC 0.6629
09343 OTHER BREAST disorders with MCC 0.7684
10011 PERFORMANCES on the ADRENAL GLANDS and the PITUITARY without CC 4.1931
10012 PERFORMANCES on the ADRENAL GLANDS, and PITUITARY GLAND with CC 4.8121
10013 PERFORMANCES on the ADRENAL GLANDS, and PITUITARY GLAND with MCC 6.0017
10021 SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, nutritional and metabolic 1.1880
DISORDERS WITHOUT CC
10022 SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, nutritional and metabolic 2.9672
DISORDERS WITH CC
10023 a SKIN GRAFT and DEBRIDEMENT of the WOUND when the ENDOCRINE, nutritional and metabolic 3.6079
DISORDERS WITH MCC
10031 PERFORMANCES for OBESITY without CC 3.3479
10032 PERFORMANCES for OBESITY with CC 4.0525
10033 PERFORMANCES for OBESITY with MCC 10.0677
10041 AMPUTATION of the LOWER LIMB in ENDOCRINE, nutritional, and METABOLICKÝCHPORUCHÁCH 1.9357
WITHOUT CC
10042 AMPUTATION of the LOWER LIMB in ENDOCRINE, nutritional, and METABOLICKÝCHPORUCHÁCH 2.7020
WITH CC
10043 AMPUTATION of the LOWER LIMB in ENDOCRINE, nutritional, and METABOLICKÝCHPORUCHÁCH 2.7020
WITH MCC
10051 PERFORMANCES on the THYROID and PŘÍŠTITNÉ GLAND, THYROGLOSSÁLNÍ PERFORMANCES without CC 1.4322
10052 PERFORMANCES on the THYROID and PŘÍŠTITNÉ GLAND, THYROGLOSSÁLNÍ PERFORMANCES with CC 1.6735
10053 PERFORMANCES on the THYROID and PŘÍŠTITNÉ GLAND, THYROGLOSSÁLNÍ PERFORMANCES with MCC 2.0576
10061 DIFFERENT PERFORMANCES in the ENDOCRINE, nutritional and metabolic DISORDERS without CC 2.6071
10062 OTHER ENDOCRINE, nutritional PERFORMANCE and metabolic DISORDERS with CC 3.2318
10063 OTHER ENDOCRINE, nutritional PERFORMANCE and metabolic DISORDERS with MCC 5.8681
10301 DIABETES, nutritional and other METABOLIC DISORDERS without CC 0.5348
10302 DIABETES, nutritional and other METABOLIC DISORDERS with CC 0.6489
10303 DIABETES, nutritional and other METABOLIC DISORDERS with MCC 0.8293
10311 HYPOVOLEMIA and ELECTROLYTE DISTURBANCES without CC 0.3777
10312 HYPOVOLEMIA and ELECTROLYTE DISTURBANCES with CC 0.5006
10313 HYPOVOLEMIA and ELECTROLYTE DISTURBANCES with MCC 0.5381
10321 CONGENITAL METABOLIC DISORDERS without CC 0.6562
10322 CONGENITAL METABOLIC DISORDERS with CC 0.9029
10323 CONGENITAL METABOLIC DISORDERS with MCC 1.8449
10331 OTHER ENDOCRINE DISORDERS without CC 0.6810
10332 OTHER ENDOCRINE DISORDERS with CC 0.6810
10333 OTHER ENDOCRINE DISORDERS with MCC 0.9772
11011 KIDNEY TRANSPLANTATION without CC 9.3263
11012 KIDNEY TRANSPLANTATION with CC 9.3263
11013 KIDNEY TRANSPLANT with MCC 10.3505
11021 GREAT PERFORMANCES on the BLADDER without CC 7.9821
11022 GREAT PERFORMANCES on the BLADDER with CC 7.9821
11023 GREAT PERFORMANCES on the BLADDER with MCC 10.9774
11031 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT without CC 2.3232
11032 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT with CC 2.7567
11033 GREAT PERFORMANCES on the KIDNEYS and the URINARY TRACT with MCC 3.8341
11041 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for PERITONEAL DIALYSIS without CC 0.4703
11042 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for PERITONEAL DIALYSIS with CC 0.6478
11043 OPERATING the ESTABLISHMENT or REVISION of the CATHETER for PERITONEAL DIALYSIS with MCC 1.8324
11051 LESS PERFORMANCES on the kidneys, URINARY TRACT and URINARY BLADDER without CC 1.2667
11052 LESS PERFORMANCES on the kidneys, URINARY TRACT and URINARY BLADDER with CC 1.3134
11053 LESS PERFORMANCES on the kidneys, URINARY TRACT and URINARY BLADDER with MCC 1.8144
11061 PROSTATECTOMY without CC 1.3700
11062 PROSTATECTOMY with CC 1.7634
11063 PROSTATECTOMY with MCC 1.8218
11071 URETHRAL and TRANSURETHRAL PERFORMANCES without CC 0.7019
11072 URETHRAL and TRANSURETHRAL PERFORMANCES with CC 0.7917
11073 URETHRAL and TRANSURETHRAL PERFORMANCES with MCC 1.0642
11081 OTHER PERFORMANCES with FAULTS and DISEASES of the kidney and urinary tract without CC 2.3063
11082 OTHER PERFORMANCES with FAULTS and DISEASES of the kidney and urinary tract with CC 3.2666
11083 OTHER PERFORMANCES with FAULTS and DISEASES of the kidney and urinary tract with MCC 6.6455
11301 MALIGNANT DISEASES of the kidneys and the urinary tract and KIDNEY FAILURE without CC 0.5265
11302 MALIGNANT DISEASES of the kidneys and the urinary tract and KIDNEY failure with CC 0.8204
11303 MALIGNANT DISEASES of the kidneys and the urinary tract and KIDNEY failure with MCC 1.3226
11311 NEPHRITIS without CC 0.5893
11312 NEPHRITIS with CC 0.6643
11313 NEPHRITIS with MCC 0.7229
11321 KIDNEY INFECTION and urinary tract without CC 0.4715
11322 KIDNEY INFECTION and urinary tract with CC 0.6615
11323 KIDNEY INFECTION and URINARY TRACT INFECTION with MCC 0.8405
11331 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ without-CC 0.5664
11332 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ with CC to 0.7284
11333 BLADDER STONES with EXTRACORPOREAL SHOCK WAVE LITOTRYPSÍ with MCC 1.1151
11341 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE without-CC 0.3905
11342 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with CC to 0.5098
11343 BLADDER STONES without EXTRACORPOREAL LITOTRYPSE with MCC 0.6138
11351 failures, reactions and complications, GRAFT or GENITOURETRÁLNÍHO DEVICE 0.3500
THE TRANSPLANT WITHOUT CC
11352 failures, reactions and complications, GRAFT or GENITOURETRÁLNÍHO DEVICE 0.8626
THE TRANSPLANT WITH CC
11353 failures, reactions and complications, GRAFT or GENITOURETRÁLNÍHO DEVICE 3.8827
THE TRANSPLANT WITH MCC
11361 signs and symptoms on the KIDNEYS and the URINARY TRACT without CC 0.5806
11362 signs and symptoms of KIDNEY and URINARY TRACT with CC 0.5806
11363 signs and symptoms of KIDNEY and URINARY TRACT with MCC 0.5806
11371 OTHER kidney and urinary tract DISORDERS without CC 0.3676
11372 OTHER kidney and urinary tract DISORDERS with CC 0.4308
11373 OTHER kidney and urinary tract DISORDERS with MCC 0.6055
12011 BIG PERFORMANCES in the pelvis in a man without CC 2.3157
12012 BIG PERFORMANCES in the pelvis in a man with CC 2.5014
12013 BIG PERFORMANCES in the pelvis in a man with MCC 3.4334
12021 PERFORMANCES on the PENIS without CC 0.6171
12022 PERFORMANCES on the PENIS with CC 1.0346
12023 PERFORMANCES on the PENIS with MCC 1.0346
12031 TRANSURETHRAL PROSTATECTOMY without CC 1.2987
12032 TRANSURETHRAL PROSTATECTOMY with CC 1.4409
12033 TRANSURETHRAL PROSTATECTOMY with MCC 1.6939
12041 PERFORMANCES on the TESTICLES without CC 0.6157
12042 PERFORMANCES on the TESTICLES with CC 0.7981
12043 PERFORMANCES on the TESTICLES with MCC 0.8446
12051 CIRCUMCISION without CC 0.4390
12052 CIRCUMCISION with CC 0.4791
12053 CIRCUMCISION with MCC 0.5187
12061 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM without CC 0.9163
12062 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM with CC 1.0792
12063 OTHER PERFORMANCES on the MALE REPRODUCTIVE SYSTEM with MCC 1.6729
12301 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM without CC 0.5522
12302 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM with CC 0.7942
12303 MALIGNANT DISEASES of the MALE REPRODUCTIVE SYSTEM with MCC 0.9381
12311 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the MALIGNANT DISEASE without CC 0.2425
12312 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the MALIGNANT DISEASE with CC 0.3204
12313 DISORDERS of the MALE REPRODUCTIVE SYSTEM, in ADDITION to the MALIGNANT DISEASE with MCC 0.3451
13011 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical VULVEKTOMIE BEZCC 3.9556
13012 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical VULVEKTOMIE with CC to 4.4586
13013 EXENTERACE PANS, RADICAL HYSTERECTOMY and radical VULVEKTOMIE with MCC 4.6091
13021 PERFORMANCES on the womb and PAIN for MALIGNANT DISEASE on the OVARY and PAIN without CC 2.9797
13022 PERFORMANCES on the womb and PAIN for MALIGNANT DISEASE on the OVARY and PAIN with CC 3.3758
13023 PERFORMANCES on the womb and PAIN for MALIGNANT DISEASE on the OVARY and PAIN with MCC 6.4743
13031 PERFORMANCES on the womb and PAIN in MALIGNANT DISEASE, OTHER THAN on the OVARY and the 2.1566
PAIN WITHOUT CC
13032 PERFORMANCES on the womb and PAIN in MALIGNANT DISEASE, OTHER THAN on the OVARY and the 2.7803
PAIN WITH CC
13033 OUTPUTS to the womb and PAIN in MALIGNANT DISEASE, OTHER THAN on the OVARY and the 4.0851
PAIN WITH MCC
13041 UTERINE and ADNEXAL PERFORMANCES in CA IN SITU and BENIGN DISORDERS without CC 1.4904
13042 UTERINE and ADNEXAL PERFORMANCES in CA IN SITU and BENIGN DISORDERS with CC 1.7010
13043 UTERINE and ADNEXAL PERFORMANCES in CA IN SITU and BENIGN DISORDERS with MCC 2.2094
13051 GYNECOLOGICAL LAPAROSCOPY or STERILIZATION without LAPAROTOMICKÁ CC 0.7839
13052 GYNECOLOGICAL LAPAROSCOPY or STERILIZATION with CC LAPAROTOMICKÁ 1.0618
13053 GYNECOLOGICAL LAPAROSCOPY or LAPAROTOMICKÁ STERILIZATION with MCC 1.4398
13061 RECONSTRUCTIVE PERFORMANCES on the FEMALE REPRODUCTIVE SYSTEM without CC 1.0415
13062 RECONSTRUCTIVE PERFORMANCES on the FEMALE REPRODUCTIVE SYSTEM with CC 1.0539
13063 RECONSTRUCTIVE PERFORMANCES on the FEMALE REPRODUCTIVE SYSTEM with MCC 1.2261
13071 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES without CC 0.3662
13072 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with CC 0.4928
13073 VAGINAL, CERVICAL and VULVOVÉ PERFORMANCES with MCC 0.6676
13081 ENDOSCOPIC INTERRUPTS the FALLOPIAN TUBE without CC 0.8259
13082 ENDOSCOPIC INTERRUPTS the FALLOPIAN TUBE with CC 0.8259
13083 ENDOSCOPIC INTERRUPTION of FALLOPIAN TUBE with MCC 0.8259
13091 dilation, CURETTAGE and KÓNIZACE without-CC 0.2845
13092 dilation, CURETTAGE and KÓNIZACE with CC to 0.3325
13093 dilation, CURETTAGE and KÓNIZACE with MCC 0.4283
13101 OTHER PERFORMANCES in DISORDERS and DISEASES of the FEMALE REPRODUCTIVE SYSTEM without CC 1.6135
13102 OTHER PERFORMANCES in DISORDERS and DISEASES of the FEMALE REPRODUCTIVE SYSTEM with CC 2.1500
13103 OTHER PERFORMANCES in DISORDERS and DISEASES of the FEMALE REPRODUCTIVE SYSTEM with MCC 4.1447
13301 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM without CC 0.6355
13302 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM with CC 0.6524
13303 MALIGNANT DISEASE of the FEMALE REPRODUCTIVE SYSTEM with MCC 0.8968
13311 INFECTION of the FEMALE REPRODUCTIVE SYSTEM without CC 0.3664
13312 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with CC 0.5603
13313 INFECTION of the FEMALE REPRODUCTIVE SYSTEM with MCC 0.8657
13321 menstrual and OTHER DISORDERS of the FEMALE REPRODUCTIVE SYSTEM without CC 0.2386
13322 menstrual and OTHER DISORDERS of the FEMALE REPRODUCTIVE SYSTEM with CC 0.3400
13323 menstrual and OTHER DISORDERS of the FEMALE REPRODUCTIVE system with MCC 0.5136
14601 BIRTH CESAREAN SECTION without CC 1.2045
14602 BIRTH CESAREAN SECTION with CC 1.4349
14603 BIRTH CESAREAN SECTION with MCC 1.6040
14611 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ without-CC 0.6671
14612 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ with CC to 0.7524
14613 VAGINAL CHILDBIRTH, STERILIZATION and/or DILATION and KYRETÁŽÍ with MCC 0.7615
14621 VAGINAL CHILDBIRTH with the power, in ADDITION to sterilization and/or dilation and CURETTAGE without CC 0.8853
14622 VAGINAL CHILDBIRTH with the power, in ADDITION to sterilization and/or dilation and CURETTAGE with CC 2.7523
14623 VAGINAL CHILDBIRTH with the power, in ADDITION to sterilization and/or dilation and CURETTAGE with MCC 3.7439
14631 VAGINAL CHILDBIRTH without CC 0.4653
14632 VAGINAL CHILDBIRTH with CC 0.5085
14633 VAGINAL CHILDBIRTH with MCC 0.5085
14641 ABORTION with DILATION and KYRETÁŽÍ, a HYSTERECTOMIES KYRETÁŽÍ or without ASPIRATION CC 0.2697
14642 ABORTION with DILATION and KYRETÁŽÍ, a HYSTERECTOMIES KYRETÁŽÍ or ASPIRATION SCC 0.3406
14643 ABORTION with DILATION and KYRETÁŽÍ, ASPIRATION or HYSTERECTOMIES SMCC KYRETÁŽÍ 0.3406
14651 ABORTION without dilation and CURETTAGE, ASPIRATION CURETTAGE or HYSTEREKTOMIEBEZ CC 0.1277
14652 ABORTION without dilation and CURETTAGE, ASPIRATION CURETTAGE or HYSTEREKTOMIES CC 0.2216
14653 ABORTION without dilation and CURETTAGE, ASPIRATION CURETTAGE or HYSTEREKTOMIES MCC 0.3044
14661 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS without CC 0.2708
14662 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS with CC 0.3807
14663 POSTPARTUM and POPOTRATOVÉ performance DIAGNOSIS with MCC 0.4520
14671 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without EXERCISING without CC 0.2178
14672 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without PERFORMANCE with CC 0.2860
14673 POSTPARTUM and POPOTRATOVÉ DIAGNOSIS without MCC performance 0.2860
14681 ECTOPIC PREGNANCY with the performance without the CC 1.4639
14682 ECTOPIC PREGNANCY with the performance with CC 1.6946
14683 ECTOPIC PREGNANCY with the performance with MCC 2.9878
14691 ECTOPIC PREGNANCY without EXERCISING without CC 1.1601
14692 ECTOPIC PREGNANCY without PERFORMANCE with CC 1.4248
14693 ECTOPIC PREGNANCY without EXERCISING with MCC 1.4552
14701 THREATENED ABORTION without CC 0.3774
14702 THREATENED ABORTION with CC 0.5052
14703 THREATENED ABORTION with MCC 0.5052
14711 FAKE BIRTH without CC 0.1588
14712 FAKE BIRTH with CC 0.3778
14713 FAKE BIRTH with MCC 0.3778
14721 OTHER ANTENATAL DIAGNOSIS without CC performance 0.4083
14722 ANTENATAL DIAGNOSIS with OTHER PERFORMANCE with CC 0.7395
14723 OTHER ANTENATAL DIAGNOSES with MCC 1.0419 performance
OTHER ANTENATAL DIAGNOSIS 14731 without EXERCISING without CC 0.3110
OTHER ANTENATAL DIAGNOSIS without 14732 PERFORMANCE with CC 0.5296
OTHER ANTENATAL DIAGNOSIS without 14733 performance with MCC 0.5296
15601 newborn, DEAD or TRANSLATED without CC < 5 days 0.3036
15602 newborn, DEAD or TRANSLATED < 5 days with CC 2.2586
15603 newborn, DEAD or TRANSLATED < 5 days with MCC 5.1102
15611 newborn, with PLANTED or EXTRACORPOREAL MEMBRANE OXYGENACÍ without-CC 9.7958
15612 newborn, with PLANTED or EXTRACORPOREAL MEMBRANE OXYGENACÍ with CC to 13.7141
15613 a NEWBORN, with PLANTED or EXTRACORPOREAL MEMBRANE OXYGENACÍ with MCC 21.7956
15621 newborn, BIRTH WEIGHT 1000 g, with the BASIC < PERFORMANCE without CC 14.0406
15622 newborn, BIRTH WEIGHT 1000 g, with the BASIC < PERFORMANCE with CC 18.5304
15623 newborn, BIRTH WEIGHT 1000 g, with the BASIC < performance with MCC 26.0405
15631 newborn, BIRTH WEIGHT 1000 g, NO BASIC < PERFORMANCE without CC 18.4531
15632 newborn, BIRTH WEIGHT 1000 g, NO BASIC < PERFORMANCE with CC 21.9691
15633 newborn, BIRTH WEIGHT 1000 g, NO BASIC < performance with MCC 25.7012
15641 newborn, BIRTH WEIGHT 1000-1499G, with the BASIC PERFORMANCE without CC 3.3735
15642 newborn, BIRTH WEIGHT 1000-1499G, with the BASIC PERFORMANCE with CC 5.6668
15643 newborn, BIRTH WEIGHT 1000-1499G, with the BASIC performance with MCC 25.9828
15651 newborn, BIRTH WEIGHT 1000-1499G, without a BASIC PERFORMANCE without CC 11.2610
15652 newborn, BIRTH WEIGHT 1000-1499G, without a BASIC PERFORMANCE with CC 11.2610
15653 newborn, BIRTH WEIGHT 1000-1499G, without a BASIC performance with MCC 14.7248
15661 newborn, BIRTH WEIGHT 1500-1999G, VÝKONEMBEZ CC 15.7340
15662 newborn, BIRTH WEIGHT 1500-1999G, with the BASIC PERFORMANCE with CC 15.7340
15663 newborn, BIRTH WEIGHT 1500-1999G, with the BASIC performance with MCC 18.4144
15671 newborn, BIRTH WEIGHT 1500-1999G, without a BASIC PERFORMANCE without CC 4.7872
15672 newborn, BIRTH WEIGHT 1500-1999G, without a BASIC PERFORMANCE with CC 4.7905
15673 newborn, BIRTH WEIGHT 1500-1999G, without a BASIC performance with MCC 7.1666
15681 newborn, BIRTH WEIGHT 2000-2499G, with the BASIC PERFORMANCE without CC 9.3235
15682 newborn, BIRTH WEIGHT 2000-2499G, with the BASIC PERFORMANCE with CC 9.9334
15683 newborn, BIRTH WEIGHT 2000-2499G, with the BASIC performance with MCC 9.9334
15691 newborn, BIRTH WEIGHT 2000-2499G, without a BASIC PERFORMANCE without CC 1.0296
15692 newborn, BIRTH WEIGHT 2000-2499G, without a BASIC PERFORMANCE with CC 2.0251
15693 newborn, BIRTH WEIGHT 2000-2499G, without a BASIC performance with MCC 4.4301
15701 NEWBORN, weight at BIRTH, 2499G > PERFORMANCE without CC 3.8738
15702 a NEWBORN, weight at BIRTH, 2499G > PERFORMANCE with CC 7.2408
15703 a NEWBORN, weight at BIRTH, 2499G > performance with MCC 9.3861
15711 newborn, BIRTH WEIGHT > 2499G, with serious ANOMALIES or HEREDITARY STATUS without 0.6064
CC
15712 newborn, BIRTH WEIGHT > 2499G, with serious ANOMALIES or HEREDITARY STATUS with CC 1.2576
15713 newborn, BIRTH WEIGHT > 2499G, with serious ANOMALIES or HEREDITARY STATUS with 2.1598
MCC
15720 newborn, BIRTH WEIGHT > 2499G, with BREATHING DIFFICULTIES 2.7797
15731 NEWBORN, weight at BIRTH, with 2499G > ASPIRATION SYNDROME without the CC 0.4534
15732 NEWBORN, weight at BIRTH, with 2499G > ASPIRATION SYNDROME with CC 2.7838
15733 NEWBORN, weight at BIRTH, with 2499G > ASPIRATION SYNDROME with MCC 4.9587
15741 NEWBORN, weight at BIRTH, congenital 2499G > or PERINATAL INFECTIONS without CC 0.9037
15742 NEWBORN, weight at BIRTH, congenital 2499G > or PERINATAL INFECTIONS with CC 0.9037
15743 NEWBORN, weight at BIRTH, congenital 2499G > or PERINATAL INFECTION with MCC 2.2048
15751 NEWBORN, weight at BIRTH, without a BASIC 2499G > PERFORMANCE without CC 0.3979
15752 newborn, BIRTH WEIGHT > 2499G, without a BASIC PERFORMANCE with CC 0.5147
15753 newborn, BIRTH WEIGHT > 2499G, without a BASIC performance with MCC 0.5817
16011 PERFORMANCES on SPLEEN without CC 2.7542
16012 PERFORMANCES on SPLEEN with CC 3.6970
16013 PERFORMANCES on SPLEEN with MCC 6.3607
16021 OTHER PERFORMANCES for BLOOD DISEASES and BLOOD-FORMING ORGANS without CC 1.0326
16022 OTHER PERFORMANCES for BLOOD DISEASES and BLOOD-FORMING organs with CC 1.2198
16023 OTHER PERFORMANCES for BLOOD DISEASES and BLOOD-FORMING organs with MCC 3.7997
16301 AGRANULOCYTOSIS without CC 1.2485
16302 AGRANULOCYTOSIS with CC 1.7070
16303 AGRANULOCYTOSIS with MCC 3.3958
16311 CLOTTING DISORDER without CC 0.9309
16312 CLOTTING DISORDER with CC 1.5257
16313 CLOTTING DISORDER with MCC 2.0088
16321 SICKLE CELL ANAEMIA without CC 0.6449
16322 SICKLE CELL ANEMIA with CC 0.8816
16323 SICKLE CELL ANEMIA with MCC 1.4041
16331 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL ANAEMIA without CC 0.7890
16332 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL ANEMIA with CC 0.8813
16333 DISORDERS of RED BLOOD CELLS, in ADDITION to the SICKLE CELL ANEMIA with MCC 1.2320
16341 OTHER blood and HEMATOPOIETIC ORGANS without CC 0.6296
16342 OTHER blood and BLOOD-FORMING organs with CC 0.8054
16343 OTHER blood and BLOOD-FORMING organs with MCC 2.2254
17011 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE without CC 1.5945
17012 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE with CC 5.2622
17013 LYMPHOMA and LEUKEMIA with HIGH PERFORMANCE with MCC 8.0771
17021 LYMPHOMA and LEUKEMIA with another PERFORMANCE without CC 1.2213
17022 LYMPHOMA and LEUKEMIA with another PERFORMANCE with CC 1.7262
17023 LYMPHOMA and LEUKEMIA with another performance with MCC 8.3899
17031 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with HIGH PERFORMANCE without 2.6079
CC
17032 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with HIGH PERFORMANCE with CC 3.6115
17033 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with HIGH PERFORMANCE with MCC 8.7045
17041 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with another PERFORMANCE without CC 2.6052
17042 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with another PERFORMANCE with CC 3.2048
17043 MYELOPROLIFERATIVE disorders and POORLY DIFFERENTIATED TUMORS with another performance with MCC 4.6114
17301 ACUTE LEUKEMIA without CC 1.7535
17302 ACUTE LEUKEMIA with CC 1.8164
17303 ACUTE LEUKEMIA with MCC 11.0888
17311 LYMPHOMA and LEUKEMIA without EMERGENT CC 1.0727
17312 LYMPHOMA and LEUKEMIA with CC EMERGENT 1.1519
17313 LYMPHOMA and LEUKEMIA with EMERGENT MCC 2.9304
17321 RADIOTHERAPY without CC 1.4970
17322 RADIOTHERAPY with CC 1.4970
17323 RADIOTHERAPY with MCC 2.5432
17331 CHEMOTHERAPY without CC 0.5844
17332 CHEMOTHERAPY with CC 0.7685
17333 chemotherapy with MCC 1.1586
17341 OTHER MYELOPROLIFERATIVE disorders and DIAGNOSIS of UNDIFFERENTIATED TUMORS without CC 0.7414
17342 OTHER MYELOPROLIFERATIVE disorders and DIAGNOSIS of UNDIFFERENTIATED TUMORS with CC 0.7672
17343 OTHER MYELOPROLIFERATIVE disorders and DIAGNOSIS of UNDIFFERENTIATED TUMORS with MCC 1.4545
18011 PERFORMANCES for infectious and parasitic diseases without CC 0.4600
18012 PERFORMANCES for infectious and parasitic diseases with CC 4.6989
18013 PERFORMANCES for infectious and parasitic diseases with MCC 11.0578
18021 PERFORMANCES for post-operative and POST-TRAUMATIC INFECTIONS without CC 1.2965
18022 PERFORMANCES for post-operative and POST-TRAUMATIC infections with CC 1.5690
18023 PERFORMANCES for post-operative and POST-TRAUMATIC infections with MCC 3.7496
18301 SEPTICEMIA without CC 1.6049
18302 SEPTICEMIA with CC 1.6049
18303 SEPTICEMIA with MCC 3.3126
18311 post-operative and POST-TRAUMATIC INFECTIONS without CC 0.6687
18312 post-operative and POST-TRAUMATIC infections with CC 0.6815
18313 post-operative and POST-TRAUMATIC infections with MCC 1.2332
18321 FEVER of UNKNOWN ORIGIN with NO CC 0.4990
18322 FEVER of UNKNOWN ORIGIN with CC 0.7014
18323 FEVER of UNKNOWN ORIGIN with MCC 0.8780
18331 VIRAL DISEASE without CC 0.5210
18332 VIRAL DISEASE with CC 0.6765
18333 VIRAL DISEASE with MCC 0.7385
18341 other infectious and PARASITIC DISEASES without CC 0.6951
18342 OTHER INFECTIOUS and parasitic diseases with CC 1.0270
18343 OTHER INFECTIOUS and parasitic diseases with MCC 1.9560
19011 OPERATING PERFORMANCE with the principal DIAGNOSIS of MENTAL ILLNESS without CC 1.6424
19012 OPERATING PERFORMANCE with the principal DIAGNOSIS of MENTAL ILLNESS with CC 2.4313
19013 OPERATING PERFORMANCE with the principal DIAGNOSIS of MENTAL ILLNESS with MCC 5.3754
19301 SCHIZOPHRENIA without CC 1.3841
19302 SCHIZOPHRENIA with CC 1.9730
19303 SCHIZOPHRENIA with MCC 2.1149
19311 PSYCHOSIS without CC 1.3775
19312 CC of PSYCHOSIS with 1.4254
19313 PSYCHOSIS with MCC 1.5908
19321 PERSONALITY DISORDERS and mood without CC 0.8606
19322 PERSONALITY DISORDERS and mood with CC 1.0315
19323 PERSONALITY DISORDERS and mood with MCC 1.5133
19331 BIPOLAR DISORDERS without CC 1.5384
19332 BIPOLAR DISORDERS with CC 1.7090
19333 BIPOLAR DISORDERS with MCC 2.5019
19341 DEPRESSION without CC 0.7245
19342 DEPRESSION with CC 1.0813
19343 DEPRESSION with MCC 1.6135
19351 ACUTE REACTIONS, PSYCHO-SOCIAL disorders and NEUROSIS in ADDITION to DEPRESSIVE without CC 0.6112
19352 ACUTE REACTIONS, PSYCHO-SOCIAL disorders and NEUROSIS in ADDITION to DEPRESSIVE with CC 0.6553
19353 ACUTE REACTIONS, PSYCHO-SOCIAL disorders and NEUROSIS in ADDITION to DEPRESSIVE with MCC 0.6856
19361 ORGANIC MENTAL DISORDERS and mental retardation without CC 0.9639
19362 ORGANIC MENTAL DISORDERS and mental retardation with CC 0.9672
19363 ORGANIC MENTAL DISORDERS and mental retardation with MCC 1.3330
19371 DEVELOPMENTAL PSYCHIATRIC DISORDERS without CC 0.9889
19372 DEVELOPMENTAL MENTAL DISORDERS with CC 0.9889
19373 DEVELOPMENTAL MENTAL DISORDERS with MCC 1.4022
19381 COMPULSIVE NUTRITIONAL DISORDERS without CC 2.3071
19382 COMPULSIVE NUTRITIONAL DISORDERS with CC 2.3071
19383 COMPULSIVE NUTRITIONAL DISORDERS with MCC 2.8580
19391 OTHER MENTAL DISORDERS without CC 0.7644
19392 OTHER MENTAL DISORDERS with CC 0.8276
19393 OTHER MENTAL DISORDERS with MCC 1.6789
20301 the HARMFUL USE of ALCOHOL, DRUGS, drugs, addiction on them, RELEASE AGAINST 0.2384
THE DOCTOR'S RECOMMENDATIONS WITHOUT CC
20302 the HARMFUL USE of ALCOHOL, DRUGS, drugs, addiction on them, RELEASE AGAINST 0.2537
THE DOCTOR'S RECOMMENDATIONS WITH CC
20303 HARMFUL USE of ALCOHOL, DRUGS, drugs, addiction on them, RELEASE AGAINST 0.2537
THE DOCTOR'S RECOMMENDATIONS WITH MCC
20311 a DEPENDENCY on drugs and alcohol rehabilitation and/or DETOX THERAPIES without CC 0.8000
20312 DEPENDENCY on drugs and alcohol rehabilitation and/or DETOXIFICATION THERAPIES with CC 0.8571
20313 DEPENDENCY on drugs and alcohol rehabilitation and/or DETOXIFICATION THERAPIES with MCC 0.9306
20321 HARMFUL use and DEPENDENCE on OPIATES and/or COCAINE without CC 0.7648
20322 HARMFUL use and DEPENDENCE on OPIATES and/or COCAINE with CC 0.7648
20323 HARMFUL use and DEPENDENCE on OPIATES and/or COCAINE with MCC 5.8964
20331 HARMFUL use and DEPENDENCE on ALCOHOL without CC 0.3741
20332 HARMFUL use and DEPENDENCE on ALCOHOL with CC 0.4569
20333 HARMFUL use and DEPENDENCE on ALCOHOL with MCC 1.5169
20341 HARMFUL use and DEPENDENCE on OTHER DRUGS without CC 0.6131
20342 HARMFUL use and DEPENDENCE on OTHER DRUGS with CC 0.6131
20343 HARMFUL use and DEPENDENCE on OTHER DRUGS with MCC 1.0951
21011 MICROVASCULAR TISSUE TRANSFER or SKIN GRAFT when INJURIES without CC 1.1682
21012 MICROVASCULAR TISSUE TRANSFER or a SKIN GRAFT at ACCIDENTS with CC 2.6911
21013 MICROVASCULAR TISSUE TRANSFER or a SKIN GRAFT at ACCIDENTS with MCC 9.7516
21021 OTHER PERFORMANCES at ACCIDENTS and COMPLICATIONS without CC 1.8442
21022 OTHER PERFORMANCES at ACCIDENTS and COMPLICATIONS with CC 2.7625
21023 OTHER PERFORMANCES at ACCIDENTS and COMPLICATIONS with MCC 7.6663
21301 INJURY on an UNDETERMINED LOCATION or in MULTIPLE PLACES without CC 2.4332
21302 INJURIES to an UNSPECIFIED LOCATION, or at SEVERAL LOCATIONS with CC 2.4332
21303 INJURIES to an UNSPECIFIED LOCATION, or at SEVERAL LOCATIONS with MCC 7.8196
21311 ALLERGIC REACTIONS without CC 0.1972
21312 allergic reactions with CC 0.2693
21313 allergic reactions with MCC 0.3690
21321 poisoning and TOXIC EFFECTS of drugs (drugs) without CC 0.2624
21322 poisoning and TOXIC EFFECTS of drugs (drugs) with CC 0.4350
21323 poisoning and TOXIC EFFECTS of drugs (drugs) with MCC 0.9160
21331 the COMPLICATIONS in the TREATMENT without CC 0.3111
21332 COMPLICATIONS when TREATING with CC 0.4579
21333 COMPLICATIONS when TREATING with MCC 0.6371
21341 MALTREATED the CHILD or ADULT SYNDROME without the CC 0.4566
21342 SYNDROME of the ABUSED CHILD or ADULT with CC 1.9586
21343 SYNDROME of the ABUSED CHILD or ADULT with MCC 1.9586
21351 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS without CC 0.3476
21352 OTHER DIAGNOSES of INJURIES, poisoning and TOXIC EFFECTS with CC 0.4225
21353 OTHER DIAGNOSIS of INJURIES, poisoning and TOXIC EFFECTS with MCC 1.0752
22501 BURNS, transfer to ANOTHER ACUTE CARE FACILITY without CC 11.4585
22502 BURNS, transfer to ANOTHER ACUTE CARE FACILITY with CC 23.5573
22503 BURNS, transfer to ANOTHER ACUTE CARE FACILITY with MCC 23.5573
22510 EXTENSIVE BURNS with SKIN GRAFT 9.0611
22521 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN GRAFT or INHAL. INJURIES without 3.3751
CC
22522 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN GRAFT or INHAL. INJURY with 7.3348
CC
22523 NEROZSÁHLÉ BURNS through the ENTIRE skin with SKIN GRAFT or INHAL. INJURY with 12.0051
MCC
22530 EXTENSIVE BURNS without SKIN GRAFT 4.5278
22541 BURNS LIMITED SCOPE AFFECTING ALL LAYERS of the skin without SKIN GRAFT 0.9102
OR INHALED INJURY WITHOUT CC
22542 BURNS LIMITED SCOPE AFFECTING ALL LAYERS of the skin without SKIN GRAFT 1.9672
OR INHALED INJURY WITH CC
22543 BURNS LIMITED SCOPE AFFECTING ALL LAYERS of the skin without SKIN GRAFT 2.5611
OR INHALED INJURY WITH MCC
22551 BURNS LIMITED SCOPE of ALL LAYERS of the SKIN without NON-CC 0.9498
22552 BURNS LIMITED SCOPE of ALL LAYERS of the skin with NON-CC 1.6484
22553 BURNS LIMITED SCOPE of ALL LAYERS of the skin with NON-MCC 1.6484
23011 OPERATING PERFORMANCE with a diagnosis of ANOTHER CONTACT with HEALTHCARE SLUŽBAMIBEZ CC 0.7265
23012 OPERATING PERFORMANCE with a diagnosis of ANOTHER CONTACT with HEALTHCARE SLUŽBAMIS CC 2.0306
23013 OPERATING PERFORMANCE with a diagnosis of ANOTHER CONTACT with HEALTHCARE SLUŽBAMIS MCC 6.2936
23301 REHABILITATION without CC 1.0090
23302 REHABILITATION with CC 1.1237
23303 REHABILITATION with MCC 1.2273
23311 symptoms and ABNORMAL FINDINGS without CC 0.4180
23312 symptoms and ABNORMAL FINDINGS with CC 0.5787
23313 symptoms and ABNORMAL FINDINGS with MCC 0.6642
23321 OTHER FACTORS AFFECTING HEALTH STATUS without CC 0.2803
23322 OTHER FACTORS AFFECTING HEALTH STATUS with CC 0.5618
23323 OTHER FACTORS AFFECTING HEALTH STATUS with MCC 1.1027
24010 HIV with the performance, with several SEVERE INFECTIONS ASSOCIATED with HIV 0.8707
24020 HIV with the performance, with an additional DIAGNOSIS of HIV-related 2.2247
24031 HIV with power, without FURTHER DIAGNOSIS RELATED with HIV without CC 0.3359
24032 HIV with power, without an ADDITIONAL DIAGNOSIS of HIV related with CC 0.3359
24033 HIV with power, without an ADDITIONAL DIAGNOSIS of HIV related with MCC 0.3359
24301 HIV with VENTILATION or NUTRITIONAL SUPPORT without CC 4.7206
24302 HIV with VENTILATION or NUTRITIONAL SUPPORT with CC 4.7206
24303 HIV with VENTILATION or NUTRITIONAL SUPPORT with MCC 4.7206
24311 HIV with OTHER HIV-related DIAGNOSIS, RELEASED through the MEDICAL RECOMMENDATIONS without 0.4735
CC
24312 HIV with another DIAGNOSIS related to HIV, RELEASED through the MEDICAL RECOMMENDATIONS with CC 0.7510
24313 HIV with OTHER HIV-related DIAGNOSIS, RELEASED through the MEDICAL recommendations with 1.1837
MCC
24320 HIV with several SEVERE INFECTIONS ASSOCIATED with HIV 0.7347
24331 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 1.7500
HIV-RELATED TUBERCULOSIS WITHOUT CC
24332 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 1.7500
HIV-RELATED TUBERCULOSIS WITH CC
24333 HIV with another DIAGNOSIS related to HIV, without a FEW SERIOUS INFECTIONS 1.7500
HIV-RELATED TUBERCULOSIS WITH MCC
24341 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 0.6383
RELATED TO HIV, TUBERCULOSIS-FREE WITHOUT CC
24342 HIV with OTHER HIV-related DIAGNOSIS, without a FEW SERIOUS INFECTIONS 0.6383
RELATED TO HIV, TUBERCULOSIS-FREE WITH CC
24343 HIV with another DIAGNOSIS related to HIV, without a FEW SERIOUS INFECTIONS 0.6383
RELATED TO HIV, TUBERCULOSIS-FREE WITH MCC
24350 HIV without FURTHER DIAGNOSIS HIV-related 0.5699
25011 CRANIOTOMY, a LARGE PERFORMANCE on the SPINE, HIP and ENDS. When MULTIPLE SEVERE 8.6354
TRAUMA WITHOUT CC
25012 CRANIOTOMY, a LARGE PERFORMANCE on the SPINE, HIP and ENDS. When MULTIPLE SEVERE 8.6354
TRAUMA WITH CC
25013 CRANIOTOMY, a LARGE PERFORMANCE on the SPINE, HIP and ENDS. When MULTIPLE SEVERE 15.7720
TRAUMA WITH MCC
25021 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA without CC 5.8418
25022 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA with CC 5.8418
25023 OTHER PERFORMANCES in MULTIPLE SIGNIFICANT TRAUMA with MCC 12.8075
25301 DIAGNOSIS on the HEAD, chest and leg when MULTIPLE SEVERE 0.9668
TRAUMA WITHOUT CC
25302 DIAGNOSIS on the HEAD, chest and leg when MULTIPLE SEVERE 1.1460
TRAUMA WITH CC
25303 DIAGNOSIS on the HEAD, chest and leg when MULTIPLE SEVERE 2.3153
TRAUMA WITH MCC
the DIAGNOSIS of MULTIPLE MYELOMA, OTHER SERIOUS 25311 TRAUMA without CC 1.1735
the DIAGNOSIS of MULTIPLE MYELOMA, OTHER SERIOUS 25312 TRAUMA with CC 1.3023
the DIAGNOSIS of MULTIPLE MYELOMA, OTHER SERIOUS 25313 TRAUMA with MCC 2.3381
88871 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS without CC 1.1598
88872 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSIS with CC 2.8373
88873 EXTENSIVE performances that DO NOT RELATE to the MAIN DIAGNOSES with MCC 6.4976
88881 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS without CC 1.0503
88882 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSIS with CC 1.0910
88883 PROSTATIC performances that DO NOT RELATE to the MAIN DIAGNOSES with MCC 2.2361
88891 PERFORMANCES of LIMITED SCOPE which does not concern the MAIN DIAGNOSIS without CC 0.5541
88892 PERFORMANCES of LIMITED SCOPE which does not concern the MAIN DIAGNOSES with CC 1.1476
88893 PERFORMANCES of LIMITED SCOPE which does not concern the MAIN DIAGNOSES with MCC 2.3088
99980 MAIN DIAGNOSIS INVALID AS LAYOFF DIAGNOSIS 0.4184
99990-0.4061
-------- --------------------------------------------------------------------------------- ------------
3.3 Basic lump-sum payment (PUZ2008) by 31.5.2009
converted, and the conversion includes health care, which was
the medical establishment for 2008 is reported not later than 31 March 2009 and
health insurance company recognized as follows:
PUP2008 = PUZhosp2008 * (1-CMalfa/CMtot) + CMalfa * ZS + PUZamb2008
where:
PUP2008 flat-rate remuneration calculated base
PUZhosp2008 part of the base flat-rate remuneration PUZ2008 for
hospital costs, which shall be as follows:
PUZhosp2008 = PUZhosp2007 * Kn
PUZhosp2007 = Vhosp * ICBref + ZUMhosp + ZULPhosp + LPhosp + KPhosp
Vhosp the total number of medical facilities
in 2007, the reported and health insurance company
recognised for services performed during the
hospitalizations, including performances in the listed
fields of medicine and consult with the examination, in accordance with
list of performances, after the deduction of points for performance
(including performances in the listed fields of medicine
and consult with the examination, according to the list of performances)
made in 2007, during the hospitalizations,
that is according to the classification included in the
the listed groups
ZUMhosp the total amount of the reimbursement of medical
the device reported and health insurance company
recognised separately posted material provided
in 2007 in connection with the performances, made
during hospitalization, with the exception of separately
the posted material provided in 2007
in connection with the performances, that were made during the
hospitalizations, which are according to the classification
included in the listed groups
ZULPhosp the total amount of the reimbursement of medical
the device reported and health insurance company
recognised separately charged to medicinal products
rendered in 2007 in connection with the performances,
made during the hospitalization, with the exception of
separately charged to medicinal products
awarded in 2007 in connection with the performances,
made during the hospitalizations, which are
According to the classification included in the listed
groups
LPhosp flat-rate amount shall be paid to the healing
preparations for ošetřovacím days and reported
health insurance company recognized for the year 2007,
with the exception of the flat-rate amounts to ošetřovacím days
reported for the year 2007 during hospitalizations, which
are according to the classification included in the listed
groups
KPhosp other health care paid in Czech Crowns
(in addition to ZUMhosp, ZULPhosp and LPhosp) and declared
health insurance company recognized, provided
medical facilities in 2007 during the
hospital admissions, with the exception of health care
rendered in 2007 during the hospitalizations,
that is according to the classification included in the
the listed groups
CMalfa number of cases, hospitalizations terminated in 2008,
which are classified according to the classification into groups
related to the diagnosis, multiplied by the indexes that
are given in section 3.4.
CMtot number of cases, hospitalizations terminated in 2008,
included in the Classification of groups related to the
diagnosis, multiplied by the indexes that are listed
in section 3.2, except in cases of hospitalization, which
are according to the classification included in the listed
groups
WS basic rate for 2008 is set at EUR 20 413 €
PUZamb2008 part of the flat-rate payment of PUZ2008 for outpatients
care, which counts all health care
provided to out-patients, including health care in
the listed fields of medicine and consult with an examination,
According to the list of performances, calculated as follows:
PUZamb2008 = PUZ2008-PUZhosp2008
3.4 Group related to the diagnosis according to the classification with indexes, used to
calculating the value of CMalfa, as referred to in section 3.3:
------ --------------------------------------------------------- ---------
IR-DRG5) group name Index
------ --------------------------------------------------------- ---------
01051 CARPAL TUNNEL RELEASE without CC 0.1705
01052 CARPAL TUNNEL RELEASE with CC 0.2192
01053 CARPAL TUNNEL RELEASE with MCC 0.2327
01451 CONCUSSION without CC 0.2502
01452 CONCUSSION with CC 0.2904
01453 CONCUSSION with MCC 0.4669
02041 PERFORMANCES on the LENS with or without VITREKTOMIE without-CC 0.5243
02042 the PERFORMANCES on the LENS with or without VITREKTOMIE with CC 0.5719
02043 PERFORMANCES on the LENS with or without VITREKTOMIE with the MCC 0.5719
03061 PERFORMANCES on SALIVARY GLAND without CC 1.0647
03062 PERFORMANCES on SALIVARY GLAND with CC 1.3239
PERFORMANCES on the SALIVARY GLAND 03063 with MCC 1.3773
05021 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP without CC 16.7875
05022 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with CC 22.0351
05023 PERFORMANCES on the HEART with the HEART-CATH LAB FLAP with MCC 22.2832
05041 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION without CC 14.5375
05042 PERFORMANCES on HEART FLAP without CARDIAC CATHETERIZATION with CC 16.3142
05043 PERFORMANCES on HEART FLAP without cardiac catheterization with MCC 18.6424
05051 CORONARY BYPASS SURGERY with HEART-CATH LAB without CC 12.0895
05052 CORONARY BYPASS SURGERY with HEART-CATH LAB with CC 14.0417
05053 CORONARY BYPASS SURGERY with HEART-CATH LAB with MCC 15.0073
05061 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION without CC 10.0195
05062 CORONARY BYPASS SURGERY without CARDIAC CATHETERIZATION with CC 10.4284
05063 CORONARY BYPASS SURGERY without cardiac catheterization with MCC 12.5552
05101 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL 6.9680
INFARCTION WITHOUT CC
05102 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL 7.0606
INFARCTION WITH CC
05103 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE with acute MYOCARDIAL 8.0973
INFARCTION WITH MCC
IMPLANTATION of PERMANENT PACEMAKER 05111 without ACUTE 6.5566
MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITHOUT CC
IMPLANTATION of PERMANENT PACEMAKER 05112 without ACUTE 6.5566
MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITH CC
IMPLANTATION of PERMANENT PACEMAKER 05113 without ACUTE 7.2851
MYOCARDIAL INFARCTION, HEART FAILURE OR SHOCK WITH MCC
05131 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL 5.7124
INFARCTION WITHOUT CC
05132 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL 5.8581
INFARCTION WITH CC
05133 PERCUTANEOUS CARDIOVASCULAR PERFORMANCE without ACUTE MYOCARDIAL 6.4009
INFARCTION WITH MCC
05311 CARDIAC CATHETERIZATION in the ISCHEMIC HEART without CC 1.0102
05312 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with CC 1.1061
05313 CARDIAC CATHETERIZATION in the ISCHEMIC HEART with MCC 1.2632
06011 BIG PERFORMANCES on the THICK and THIN INTESTINE without CC 3.6731
GREAT PERFORMANCES on the THICK 06012 and THIN INTESTINE with CC 4.2191
06013 BIG PERFORMANCES on the THICK and THIN INTESTINE with MCC 5.6110
06051 PERFORMANCES on APENDIXU without-CC 1.0370
06052 PERFORMANCES at APENDIXU with CC to 1.2758
06053 PERFORMANCES on APENDIXU with MCC 1.8180
LAPAROTOMICKÉ PERFORMANCE 06081 INGUINAL, Femoral, UMBILICAL 0.7236
OR EPIGASTRIC HERNIA WITHOUT CC
LAPAROTOMICKÉ PERFORMANCE 06082 INGUINAL, Femoral, UMBILICAL 1.0194
OR EPIGASTRIC HERNIA WITH CC
LAPAROTOMICKÉ PERFORMANCE 06083 INGUINAL, Femoral, UMBILICAL 1.3567
OR EPIGASTRIC HERNIA WITH MCC
07041 LAPAROSCOPIC CHOLECYSTECTOMY without CC 1.6302
07042 LAPAROSCOPIC CHOLECYSTECTOMY with CC 1.8555
07043 LAPAROSCOPIC CHOLECYSTECTOMY with MCC 2.2424
SPINAL FUSION 08031, not for the DEFORMITY without CC 6.9862
08032 FUSION spine, NOT for DEFORMITY with CC 8.7586
08033 FUSION of the SPINE, not for DEFORMITY with MCC 10.5248
08081 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE 2.6233
LARGE JOINTS WITHOUT CC
08082 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE 3.1903
LARGE JOINTS WITH CC
08083 PERFORMANCES on the HIPS and thigh BONES, in ADDITION to the REPLANTACE 3.9092
LARGE JOINTS WITH MCC
10051 PERFORMANCES on the THYROID gland and PŘÍŠTITNÉ THYROGLOSSÁLNÍ PERFORMANCE 1.4322
WITHOUT CC
10052 PERFORMANCES on the THYROID gland and PŘÍŠTITNÉ THYROGLOSSÁLNÍ PERFORMANCE 1.6735
WITH CC
10053 PERFORMANCES on the THYROID gland and PŘÍŠTITNÉ THYROGLOSSÁLNÍ PERFORMANCE 2.0576
WITH MCC
12031 TRANSURETHRAL PROSTATECTOMY without CC 1.2987
12032 TRANSURETHRAL PROSTATECTOMY with CC 1.4409
12033 TRANSURETHRAL PROSTATECTOMY with MCC 1.6939
13091 dilation, CURETTAGE and KÓNIZACE without-CC 0.2845
13092 dilation, CURETTAGE and KÓNIZACE with CC to 0.3325
13093 dilation, CURETTAGE and KÓNIZACE with MCC 0.4283
14601 BIRTH CESAREAN SECTION without CC 1.2045
14602 BIRTH CESAREAN SECTION with CC 1.4349
14603 BIRTH CESAREAN SECTION with MCC 1.6040
14631 VAGINAL CHILDBIRTH without CC 0.4653
14632 VAGINAL CHILDBIRTH with CC 0.5085
14633 VAGINAL CHILDBIRTH with MCC 0.5085
15751 NEWBORN, weight at BIRTH, without a BASIC 2499G > 0.3979
PERFORMANCE WITHOUT CC
15752 NEWBORN, weight at BIRTH, without a BASIC 2499G > 0.5147
PERFORMANCE WITH CC
15753 NEWBORN, weight at BIRTH, without a BASIC 2499G > 0.5817
PERFORMANCE WITH MCC
------ --------------------------------------------------------- ---------
3.5 the above flat-rate reimbursement of the resulting folder (PUV2008)
medical equipment in 2008, equal to the amount of the calculated base
the flat-rate compensation (PUP2008), if the base flat-rate remuneration is calculated
(PUP2008) will not be in the appropriate half of 2008 less than 104% share
the base flat-rate remuneration and the coefficient of increase (PUZ2008/CN) and at the same time
will not be higher than 106% of this share.
3.6 If the base flat-rate remuneration calculated (PUP2008) will be less than
104% of the base flat-rate remuneration and koeficintu growth
(PUZ2008/CN), the resulting lump-sum payment of as PUV2008 folder
min as follows:
PUV2008 min = 1.04 * (PUZ2008/CN)
3.7 If a flat-rate remuneration calculated base (PUP2008) will be greater than the
106% of the base flat-rate remuneration and the coefficient of increase in
(PUZ2008/CN), the resulting lump-sum payment of as PUV2008 folder
Max as follows:
PUV2008 max = 1.06 (PUZ2008/CN)
3.8 the resulting lump payment folder (PUV2008), or
PUV2008 min or max PUV2008 belongs to the medical device, if:
3.8.1 the medical facility and is reported by the health insurance fund shall recognise a number of
hospital admissions for the year 2008 included in the groups related to the diagnosis of
According to the classification, multiplied by the Indexes, which are listed in section 3.2, in the
of at least 95% of the medical facilities reported and health
insurance recognised in the number of hospital admissions for the year 2007 included in the
groups related to the diagnosis, multiplied by the indexes of the classification,
that are listed in section 3.2; in an investigational or reference period
do not count towards hospitalization, which are classified according to the classification
the listed groups,
3.8.2 medical device reports and health insurance fund recognised by the number of
points for performance is provided in the out-patient care for the year 2008 in the amount of
at least 95% of the medical facilities reported and health insurance company
recognised the number of points for performance granted under the ambulatory care per year
2007.
3.9 If the medical establishment reported and health insurance company
recognized by the number of hospital admissions for the year 2008 included in the groups of related
to the diagnosis by classification, multiplied by the Indexes, which are listed in the
section 3.2, will be less than 95% of medical facilities reported and
health insurance company recognized the number of hospital admissions for the year 2007
included in the groups related to the diagnosis according to the classification,
multiplied by the Indexes, which are listed in section 3.2, the resulting lump
remuneration (PUV2008, or PUV2008 PUV2008 min or max) for the year
2008 will be reduced by the same number of percentage points, of which 95 have been reached
% values according to section 3.8.1, multiplied by the index (PUP2008-PUZamb2008)/
PUP2008.
3.10 If medical facilities reported and health insurance company
recognized by the number of points for performance granted under the ambulatory care per year
2008 will be less than 95% of the number of medical facilities reported
and health insurance company recognized for performance granted under
out-patient care for the year 2007, the resulting lump payment (PUV2008,
where appropriate, the min or max PUV2008 PUV2008) for the year 2008 shall be reduced by the same
the number of percentage points, of which 95% of the value has not been achieved in accordance with section
3.8.2, multiplied by the index of the PUZamb2008/PUP2008. For the purposes of calculating the number of
points referred to in section 3.8.2 is reported in connection with the performances of the day
care on a bed, according to the list of services considered as provided in the performance
the out-patient care.
3.11 the resulting lump payment (PUV2008, or PUV2008 min or
PUV2008 max) is reduced by the sum of the points calculated in points
3.9 and 3.10.
4. where in the clinic of changes in scale and
the structure provided by the paid care in comparison with the year 2007, and health
the insurance company will approve these changes, taking into account the contract, including
quantifying the increase (reduction) payments.
5. Health insurance shall take into account the change in the volume of reported and health
insurance company recognized by the extremely costly healthcare provided in
2008 compared to 2007, when this care is not covered in any other way.
Extremely costly health care for the purposes of this Ordinance means
healthcare provided to the insured person whose medical facility
the volume exceeds the amount of $ 1 0000 0000. To the volume of health care
counted separately charged medicines, especially the posted material
and the point value of the medical procedures according to the list of performances with the value
in accordance with § 2.
6. The flat-rate remuneration referred to in paragraphs 1 to 5 shall not include health care
provided by the insured from the EU. If this care on the basis of the contractual
the arrangement covered by list of performances, the point value is determined in § 2.
B) institutional care according to § 3 (2). 2
1. A flat rate per one day of hospitalization
a) flat rate for one day of hospitalization shall be determined for each
the category of the patient and the type of treatment the day alone, according to the list
performance and includes the value of the respective treatment delivery, including Director
assigned to ošetřovacímu date and category of the patient, according to the list
the performances, by the standard amount that is payable under section 17 of the medicinal products
paragraph. 7 of the Act and medical procedures, which shows income and
layoff examination referred to in the list.
(b) the amount of the flat-rate tariff for) one day of hospitalization is determined in the amount of
102% of the flat rate per treatment day belonging to a healthcare
with the exception of psychiatric specialised therapeutic institutes
returning the treatment days 00021 and list of performances, 0005 in
2007.
c) above the flat rate per day of hospitalisation in psychiatric
specialised therapeutic institutes, returning the treatment days 00021 and 00026
According to the list of performances shall be fixed at 103% of the flat rate per
treatment day belonging to a medical facility in 2007.
(d)) if the in the clinic of changes in scale and
the structure provided by the paid care in comparison with the year 2007, and health
the insurance company will approve these changes, taking into account the contract, including
quantifying the increase (reduction) payments.
2. Reimbursement of out-patient care, special care and special constitutional
care
and for outpatient health care) paid by performance list
point value determined in § 2.
(b)) for the special outpatient care provided under section 22 (b). (c))
the law, paid according to the list of performance shall be in the amount of point value
1.03.
(c)) for special care provided in health facilities
the hospice type according to § 22a of the law, paid according to the list of performances,
provides the value of the item in the amount of € 1.03.
C) regulatory restrictions
1. If the total remuneration for medicinal products and medical devices
prescribed by the medical device competent health insurance policy holders
insurance in 2008, with the exception of medical devices
the review by a doctor approved, exceeds 105% of remuneration for medicinal products
and medical devices prescribed in 2007, with the exception of
medical devices approved by the review by a doctor, medical
the insurance company within the total payment of the medical facility to reduce the payment
the amount corresponding to not more than 40% of such excess. In the total remuneration
will be included as well as supplements for medicinal products, for which the prescribing
the doctor has ruled out the possibility of replacement pursuant to § 32 para. 2 of the Act.
2. in the event that the medical facilities provided in 1. semester or in the
2. half of 2008 Healthcare 100 and less relevant to insurance policy holders
health insurance companies, health insurance does not apply the regulation referred to
in point 1.
Annex 2
The value of the item, the amount of the reimbursement of health care and regulatory restrictions pursuant to § 4
And kapitačně) combined the performance payment
1. the amount of the payment kapitační is calculated by the number of passenger policy holders
appropriate health insurance, multiplied by the base rate laid down
on one of the insured person is registered with the health insurance companies on the
calendar month. The basic rate according to the first sentence shall be at the rate of 42
CZK. The number of insured persons of the relevant health insurance companies ' profits are
calculated by multiplying the number of medical institutions registered
competent health insurance company policyholders age
the groups referred to in point 4, the index referred to in section 4 of romanticism. The amount of the basic
rates, where applicable, the total amount of the payment may be increased when the
the conditions laid down in the contract between the health insurance company and
the medical establishment. This increase must not be contrary to the health
premiums health insurance plan.
2. for medical procedures not included in kapitační payments, health
performances to be unregistered, the competent health insurance company and the insured person for
the insured person from the EU, the medical establishment declared and health
insurance recognised, by the list of performance shall be the value of the
point in the amount of CZK 1.
3. for the performance of the transport in the visitors service, paid for by list of performances
down the point value of 0.91 Eur.
4. Index expresses the ratio of the cost of insured persons in the age group
against the costs of insured persons in the age group 15 to 19 years of age.
Age group and indexes:
+----------------+-------+
| Age group | Index |
+----------------+-------+
| 0-4 years | 3.80 |
+----------------+-------+
| 5-9 years | 1.65 |
+----------------+-------+
| 10-14 years of age | 1.30 |
+----------------+-------+
15-19 years, | | 1.00 |
+----------------+-------+
20-24 years, | | 0.90 |
+----------------+-------+
| 25-29 | 0.95 |
+----------------+-------+
30-34 years, | | 1.00 |
+----------------+-------+
35-39 years, | | 1.05 |
+----------------+-------+
40-44 years, | | 1.05 |
+----------------+-------+
45-49 years, | | 1.10 |
+----------------+-------+
50-54 years, | | 1.35 |
+----------------+-------+
55-59 years, | | 1.45 |
+----------------+-------+
60-64 years, | | 1.50 |
+----------------+-------+
65-69 years, | | 1.70 |
+----------------+-------+
70-74 years, | | 2.00 |
+----------------+-------+
75-79 years, | | 2.40 |
+----------------+-------+
80-84 years, | | 2.90 |
+----------------+-------+
85 years and over, | | 3.40 |
+----------------+-------+
(B)) the combined kapitačně output with payment by calling kapitace
1. the amount of the payment by calling kapitační with kapitace is determined by (a).
And) point 1. Call kapitace is provided in cases where practical
a doctor for adults or general practitioner for children and adolescents has
on the geographical conditions, a small number of insured persons of the relevant health
the insurance company than the 70% of the national average in the number of insured persons
competent health insurance company (national average number of down
always for the calendar year according to data from the central registry
insured persons, managed by the General health insurance company of the United
the Republic) and the provision of such health care is necessary to meet the
duty of health insurance pursuant to § 46 para. 1 of the law.
2. Call kapitace can provide up to 90% kapitační payment
calculated on the nationwide average number of insured persons of the relevant health
the insurance company. He is involved in health insurance, with whom he has
medical equipment contract for the provision and payment of medical
care, which corresponds to the percentage share of its policy holders of registered
This medical institution from the total number of insured persons all
health insurance companies registered by the medical establishment.
3. For payment according to the list of performances with (a). A) points 2 and 3 shall apply
by analogy.
(C) health care paid by) the list of performances
For health care paid for by list of performances and for transport in the
Guestbook service, paid for by list of performance shall be the point value
in the amount of € 0.91.
D) regulatory restrictions
1. Regulations for the prescribed medicines and medical devices and
for the requested care in the fields of Medicine (listed in the requested care
do not include medical procedures carried out by the screening mammografického
the medical establishment, which has insurance on the
the provision of such medical procedures agreements):
1.1. If the average remuneration for medicinal products and medical
the means prescribed by the medical device related to one
equivalents of the insured person exceeds by more than 20% of the national average
remuneration for the prescribed medicines and medical devices, it is
health insurance company authorized to exercise regulatory reduction of up to 25% of the
the excess. The average payment per insured person is converted
includes the supplements for medicinal products, for which the prescribing
the doctor has ruled out the possibility of replacement pursuant to § 32 para. 2 of the Act.
1.2. If the average payment for the requested care in listed
specializations according to the list of procedures related to one the equivalised
of the insured person exceeds by more than 20% of the national average remuneration for the
pull the care in the listed fields of medicine, is a health insurance company
entitled to exercise regulatory reduction of up to 25% of the excess.
2. Regulatory constraints referred to in point 1.1 and 1.2 shall not apply, if
medical facilities justifying medical care provided on the
the basis has exceeded the average of payments referred to in point 1.1, where appropriate,
1.2.
3. Regulatory constraints referred to in point 1.1 and 1.2 shall further not apply if
medical device register in 2007 or 2008 50 and less
insured persons the competent health insurance company or has provided health care
50 and less non-registered persons insured the relevant health insurance
or in the case of healthcare provided to the insured from the EU.
4. Regulatory constraints referred to in point 1.1 shall not apply if the total remuneration
for all the medicines and medical devices prescribed by
General practitioners for adults and general practitioners for children and adolescents in
the year 2008 shall not exceed the estimated amount of the remittances to this kind of health
care for the year 2008 based on the health insurance plan of the appropriate
health insurance companies.
5. the regulatory restriction under section 1.2 shall not apply if the total remuneration
for the requested care in the listed fields of medicine in 2008, shall not exceed the
the estimated amount of remittances to this kind of health care for the year 2008
based on the health insurance plan of the appropriate health
the insurance company.
6. the insurer is entitled to assert regulatory reduction by
points 1.1 and 1.2 for a maximum amount corresponding to 15% of the volume of payments
provided in the health insurance medical facility for
kapitační payment and medical procedures, reduced by the amount of remuneration for particular
posted material and separately charged medicinal products for the year 2008.
Annex 3
The value of the item, the amount of the reimbursement and regulatory restrictions pursuant to § 5
And the point value and the amount) reimbursement
1. the amount of the remuneration shall be fixed according to the list provided by remuneration for performance
medical procedures-valued point of
and in 1.05 Eur) for healthcare facilities providing hemodialysis treatment,
for medical device reporting performance expertise-910
psychotherapy according to the list of performances together with the ošetřovacím the date of the daily
According to the list of performances
(b) $ 1.10) for health care facilities contracting expertise-901
Clinical Psychology, 903-927-clinical speech therapy and orthoptist,
According to the list of performances
(c)) $ 1 for all other health care facilities. In the cases specified in
section 6. (a). and you may pay the health insurance company) healthcare
equipment medical procedures for the expertise achieved in real terms the value of the
point multiplied by the index increase in remittances, laid down in point 2.
2. unless otherwise stipulated, the total amount of the reimbursement of medical
device
and providing health care in) one of the skill does not exceed
which is calculated as follows:
POPzpo x PUROo x In
where:
POPzpo number of unique insured persons treated in the
expertise of medical facilities in the relevant
half of 2008; unique by the insured person for the purposes of
This Decree means one insured person competent
health insurance companies treated in medical facilities
in that, at least in the corresponding half of the skill
Once, while not applicable, whether it is
about the treatment in the context of their own care or care requested.
If the insured person the medical establishment
in the expertise of the treated in the half-year
more than once, includes the number of unique policy holders
the health insurance companies treated in the
expertise only once
PUROo the average remuneration for medical procedures, including especially
the posted material and separately charged to medicinal
the one unique insured
treated in the expertise of the medical institutions
in the half-year, 2007
In the index increase in payments, which shall be at least 1.06
(b)) providing health care in multiple fields of medicine does not exceed the amount
equal to the sum of the amounts for individual expertise, where the amount of the
individual expertise is calculated as follows:
POPzpo x PUROo x In
where:
POPzpo number of unique insured persons treated in the
expertise of medical facilities in the relevant
half-year 2008
PUROo is calculated as follows:
PUROo = PPBROo x RDHB + PUZUMROo + PUZULPROo
where:
PPBROo average number of medical facilities declared and
health insurance company recognized points on one
the unique skill of the insured in the treated
the medical establishment in the half-year, 2007
RDHB realistically achieved point value for ambulatory
specialized care, provided by the medical
equipment for health insurance in the relevant
half of 2007, which is defined as the proportion of the total
the remuneration provided by the medical facility health
insurance for outpatient specialist care
reduced by the amount of remuneration for the separately posted material and
separately charged for the medicinal product
half of 2007 and the total number of points per out-patient
specialized care medical facilities
reported for the half-year 2007 and health
insurance company approved
PUZUMROo the average remuneration for the separately posted material on the
one of the unique expertise of an insured person in a given
a medical facility in the half-year, 2007
PUZULPROo the average remuneration of a particularly charged to medicinal products
one of the unique expertise of an insured person in a given
in a medical facility in the half-year, 2007
In the index increase in payments, which shall be at least 1.06
For medical devices, which in the reference period
did not exist, or that provides care in the
expertise, the health insurance company for the purpose of calculating the total
the amount of the payment of remuneration to the average use of one unique
of the insured person during a reference period of comparable health
device.
3. in the case of medical devices, where half of 2007 compared to the competent
the changes range from nasmlouvaného provided by the health care
some expertise (i.e. change the spectrum of the contracted performance)
the average payment per unique person, the amount of
payment of the medical device as defined in point 2, increased by the value of the
medical facilities and health insurance company declared the recognised
the newly contracted medical procedures, including especially the posted
material and separately charged to medicinal products. The newly contracted
the performances are for these purposes will be appreciated according to the list of performance using the value
the point of 0.95 €.
4. the insurer shall take into account cases where further medical
the device proves that increased the average cost of separately billed
material and separately charged medical preparations per one unique
of the insured person in a given skill were caused by changing the amount or the method of
their remuneration, or due to changes in the structure of the treated
policy holders.
5. Beyond the total amount of remuneration laid down in point 2. shall be borne by the health
insurance company provided health care according to the list of performances (including
especially the posted material and separately charged of medicinal products),
remuneration for provided medical procedures with the value of the point set out in the
the level of 0.30 €. The number of points covered by the this value is determined as the
the difference between the total number of medical facilities declared and
health insurance company recognized points and number of points, which is determined
as a proportion of the total amount of remuneration laid down in point 2., after deduction of the
medical facilities and health insurance company reported a recognised
especially the posted material and separately charged of medicinal products and
the point values laid down in point 1. c). If this difference has a negative
the value of, the provisions of this section shall not apply.
6. the provisions of paragraph 2. and (5). do not apply:
and) in the case of medical equipment as specified in point 1. (a). (c)), which in
the half-year 2007 or 2008, within a single expertise treating 50
and less unique policy holders when the contracted value of relative
the capacity numbers 1.00. The limit of 50 treated policyholders is unique
Converts the value of the IM capacity for the number of proportional
expertise. The relative simultaneously expresses the number size capacity
nasmlouvaného the scope of health care for the expertise provided by
one carries the performance ^ 3), the health insurance company,
(b)) at health care facilities contracting 901 (clinical skills
Psychology), 903 (clinical speech therapy), 927 (orthoptist)
medical device reporting health performance expertise 910
(psychotherapy), together with ošetřovacím day care centres and day
outpatient dialysis equipment expertise of 108 (Nephrology)
c) in the case of healthcare provided to the insured from the EU.
B) regulatory restrictions
1. Regulations for the prescribed medicines and medical devices and
for the requested care in the fields of Medicine (listed in the requested care
do not include medical procedures mammografického screening and screening
cervical cancer performed by the medical establishment, which has
the health insurance company on the provision of such medical procedures
concluded a contract):
1.1. If medical equipment reaches the average payment per
unique insured for the prescribed medicines and medical
resources in the corresponding half of 2008 higher than 110% of the average of the remuneration
one of the unique insured's prescribed medicines and
medical devices in the half-year 2007, health
the undertaking may medical facility, after the end of the year 2008, to reduce the
payment of the amount corresponding to 40% of the additional costs for the prescribed
medicinal products and medical devices (over 110%), and the ways in
contained in the contract of medical equipment and health insurance companies.
The average payment per insured person will be included as well as a unique
supplements for medicinal products, for which the prescribing doctor to exclude
the possibility of replacement pursuant to § 32 para. 2 of the Act.
1.2. If the medical device reaches the average payment per
the unique pull the insured's care in the listed fields of medicine in
the half-year 2008 higher than 110% of the average remuneration per
the unique of the insured person in the half-year, 2007, the health insurance company
can medical facility, after the end of the year 2008, to reduce the payment of the
the amount corresponding to 40% of the additional costs of the requested care (over 110
%), and ways the Treaty health care facility, and
health insurance companies.
1.3. the regulatory restriction referred to in point 1.1 and 1.2 shall not apply, if
medical facilities justifying medical care provided on the
the basis has exceeded the average of payments referred to in point 1.1, where appropriate,
1.2.
1.4. Regulatory constraints referred to in point 1.1 and 1.2 shall further not apply if
the total remuneration for the medical establishment to the prescribed medicines and
medical devices and pull the care in the listed
proficiency in the half-year 2008 will not exceed 105% of the total remuneration
in the half-year, 2007, and medical equipment in the
half of 2008 undergo at least 90% of insured persons against the unique
competent half-year 2007.
1.5. the regulatory restriction referred to in point 1.1 shall not apply if the total
payment for all the medicines and medical devices prescribed by
in the out-patient health care facilities providing out-patient
specialized care in 2008, shall not exceed the estimated amount of the remittances to
This kind of health care in the year 2008 based on the disabled
competent health insurance company insurance plan.
1.6. If, on the basis of the calculation of the regulatory restrictions according to point 1.1
or in accordance with section 1.2 should be health insurance asserted regulatory
reduction of more than 15% of the medical device, it shall
health insurance then the limits for the application of the relevant
regulatory constraints so that the number of health facilities with
rainfall does not exceed the calculated regulatory level of 15% of all
of the medical device.
1.7. in the case of medical devices, where half of 2007 compared to the competent
nasmlouvaného has changed the scope of medical services (changing number of
the holders of power authorized to prescribe medicines and
medical devices and require care in listed
fields of Medicine), in agreement with the health insurance company health
the average values of the device in the half-year 2007 remittances for the following
the purpose of a proportionally adjusted.
1.8. in the case of a medical device that in 2007 or in the part of the year
2007 did not exist, or not concluded a contract with health
the insurance company, health insurance company may use for the purposes of the application of the
regulatory restrictions referred to in points 1.1 and 1.2 of the reference value
comparable medical facilities.
2. If the medical facility treating in the half-year 2007 or
in the half-year 2008 in the expertise of 50 and less unique
policy holders when the contracted value of relative capacity numbers 1.00,
health insurance company this expertise does not include in the calculation of regulation under the
points 1.1 and 1.2. The limit of 50 treated policyholders is unique
Converts the value of the IM capacity for the number of proportional
expertise.
3. the regulatory restriction under section 1.2 shall not apply if the total remuneration
for the requested care in the listed fields of medicine in 2008, shall not exceed the
the estimated amount of remittances to this kind of health care for the year 2008
based on the health insurance plan of the appropriate health
the insurance company.
4. the insurer is entitled to assert regulatory reduction by
points 1.1 and 1.2 for a maximum amount corresponding to 15% of the volume of payments
provided in the health insurance medical facility for
medical procedures, reduced by the amount of remuneration for the separately posted material and
separately charged to the medicinal products for the year 2008.
Annex 4
Point value and the amount of the payments referred to in section 7 of the
1. The flat-rate remuneration
1.1 the flat-rate payment for 1. and 2. half of 2008 be set at 102%
the volume of payments for medical procedures, including especially the posted material and
separately charged of medicinal products, medical devices reported
and health insurance company recognized in the corresponding half of 2007. If it has been
medical device 1. or 2. half of 2007 health
insurance recognised and granted more than 102% of remuneration for the
half of 2006, without payment, points awarded by the coefficient of the variable
costs the amount of the flat-rate payment equal to the amount of the flat-rate remuneration for
the half-year 2007.
1.2 If a medical facility provides health care expertise
809 (radiodiagnostics) according to the list of performances as well as in other fields of medicine
referred to in section 7, provides for a flat-rate remuneration separately for expertise and 809
separately for other expertise.
1.3 If the medical device with the health insurance company contracted
89711-89725 performance according to the list of performances, the health insurance company
These performances from the flat-rate remuneration set aside and pay according to the list of performances with the
the value of the point, which is set at EUR 0.80 CZK.
1.4 after the evaluation of the total volume of provided health care in the
the half-year 2008 will modify the flat-rate health insurance
payment as follows:
and if the medical device reports) in the half-year 2008, the number of
, that health insurance will recognize, in the span of 98-102%
the reference to the number of points, the amount of flat-rate remuneration laid down in point 1.1:
does not change; the number of points of reference means the number of medical facilities
reported, health insurance company approved and paid in full
points in the half-year 2007. The number of reported points shall be included
only medical procedures that were medical institutions of health
the insurance company reported a 1. half of 2007 at the latest by 31 December 2005. October 2007 and
health insurance company recognized and paid until 31 December 2006. in December 2007, and in 2.
half of 2007, reported by 30. April 2008 and health
insurance recognised until 31 March 2006. May 2008,
(b) if the medical device reports) in the half-year 2008, the number of
, that health insurance company considers less than 98% of the reference
the number of points, the flat-rate remuneration referred to in point 1.1 shall be adjusted by multiplying the
coefficient of performance changes, which shall be calculated as the proportion of reported and
recognised by the number of points in the half-year 2008 and the reference number of
,
(c) if the medical device reports) in the half-year 2008, the number of
, that health insurance company must recognize a higher than 102% of the reference
the number of points, it modifies the health insurance a fixed remuneration as follows:
PB
UPS = PS + [(PS-x------------PS) x PKvn]
RPB
where:
UPS modified flat-rate remuneration
The flat-rate remuneration determined in accordance with PS 1.1 and 1.2
PB number of medical facilities declared to the points for
the half-year 2008 health insurance
recognised
RPB reference points
PKvn average variable costs
PKvn coefficient is determined for the expertise of 809
0.7 and other expertise in the amount of 0.5.
1.5 To the flat-rate remuneration referred to in points 1.1 to 1.4, the health
care provided to the insured from the EU, the contracted performance mammografického
screening and cervical screening.
1.6 If medical equipment has provided the half-year, 2007
health care less than 100 unique treated the insured or not
establish a fixed remuneration shall be provided by the health care
According to the list. The value of the point are set out in point 2.
2. Health care was paid according to the list of performances
2.1 for the contracted performance mammografického screening and health
care provided in 809 by list of performance skills, paid for by
list of performance shall be the point value in the amount of $ 1.07.
2.2 for the contracted cervical screening performance, paid by
list of performance shall be the point value in the amount of CZK 1.
2.3 for healthcare provided in the fields of medicine, 801, 802 222, 804,
805, 807, 812-819, 822 and 823, according to the list of performances, paid by
list of performance shall be the point value of 0.89 €.
2.4 For the contracted performance 89711-89725, according to the list of performances
paid by list of performance shall be the point value amounting to 0.80 CZK.
2.5 for healthcare provided to the insured from the EU, paid by
list of performance shall be the value of the point referred to in 2.1 to 2.4.
Annex 5
Point value and the amount of payments under section 8
1. the value of point is determined in the amount of $ 1.11 for ambulatory health care
a device that provides medical care in the expertise of 925 with the availability of 24
hours 7 days a week.
2. Point value shall be fixed at Eur 0.94 for ambulatory health care
device
and skill, 911)
(b)) that do not provide health care in the expertise of 925 with the availability of 24
hours 7 days a week.
3. for health care provided in 921, the value of the skill point
down in the amount of CZK 1.
4. For transport in the visitors service, paid for by list of performances
the value of the point set at EUR 0.91 Eur. These performances not covered by the
the provisions of points 5. and 6.
5. the health care provided by the medical establishment to 110%
the calculated volume modified, as appropriate, in accordance with section 7, shall be paid by the
list of performances with the value of the point referred to in points 1 to 3. This volume is
calculated as follows:
POPho
PBro x--------------
POPro
where:
PBro total number of medical facilities reported and
health insurance company recognized for the
half of 2007
The total number of unique POPho policyholders treated
the medical establishment in the half-year 2008
POPro the total number of unique policy holders treated
the medical establishment in the half-year, 2007
6. the health care provided by the medical establishment in the expertise of 925
over 110% of the volume calculated according to paragraph 5, where appropriate, adapted by
section 7, shall be paid to the value of EUR 0.43 € point, with respect to the provision of
health care availability 24 hours 7 days a week, in the other
cases in the fields of medicine and 911 925-valued point of 0.36 Eur and
921-valued skill point of 0.40 €.
7. If in the clinic of changes in scale and
the structure provided by the paid care in comparison with the year 2007, and health
the insurance company will approve these changes, taking into account the contract, including
quantifying the increase (reduction) payments.
8. The provisions of points 5 and 6 shall not apply if the health care facility
treating 50 and less unique policyholders in the half-year 2007.
9. Health insurance medical facility may arrange for monthly
interim payment either in the amount of medical facilities reported
and health insurance company recognized healthcare for any month, or
equal to one-sixth of the 103% of remuneration in the half-year, 2007
While the chosen form of health insurance will maintain throughout the
half of the year. A preliminary consideration for the half-year, health insurance
financially settles no later than 150 days after the completion of the relevant
half-year 2008.
Annex 6
Point value and the amount of the reimbursement in accordance with § 9
1. The value of the point shall be at the rate of 1.02 €.
2. for the performance of the transport in the visitors service, paid for by list of performances
the value of the point set at EUR 0.91 Eur. These performances not covered by the
the provisions of point 3.
3. for health care provided by the medical establishment over the calculated
volume, paid according to the list of performance shall be in the amount of point value
0.59 €. This volume is calculated as follows:
POPho
PBro x--------------
POPro
where:
PBro total number of medical facilities reported and
health insurance company recognized for the
half of 2007
The total number of unique POPho policyholders treated
the medical establishment in the half-year 2008
POPro the total number of unique policy holders treated
the medical establishment in the half-year, 2007
4. where in the clinic of changes in scale and
the structure provided by the paid care in comparison with the year 2007, and health
the insurance company will approve these changes, taking into account the contract, including
quantifying the increase (reduction) payments.
5. the provisions of paragraph 2 shall not apply if the health care facility and treating
50 and less unique policy holders in the appropriate half-year 2007.
6. Health insurance medical facility may arrange for monthly
a preliminary payment of either of the values of the medical establishment declared,
and health insurance company recognized by health care, for any month, or
equal to one-sixth of the 103% of remuneration in the half-year, 2007
While the chosen form of health insurance will maintain throughout the
half of the year. A preliminary consideration for the half-year, health insurance
financially settles no later than 150 days after the completion of the relevant
half-year 2008.
Annex 7
Point value and the amount of the reimbursement in accordance with § 11
1. The value of the point shall be
and in the amount of $ 0.94) for healthcare facilities providing health care
in continuous operation,
(b)) of 0.88 Eur for healthcare facilities to provide health
care in continuous operation.
2. the health insurance company may over 103% of the calculated volume adjust
the value of the point specified in the point. 1. for health care facilities
referred to in point 1. (a). and to 0.90 €), for health care facilities
referred to in point 1. (a). (b)) to 0.80 CZK. This volume is calculated as follows:
POPho
PBro x--------------
POPro
where:
PBro total number of medical facilities reported and
health insurance company recognized for year 2007
The total number of unique POPho insured persons who have been
in 2008, granted the right to health
POPro the total number of unique insured persons who have been
in 2007, granted the right to health
3. the provisions of paragraph 2, shall not apply to medical devices, which
2007 or 2008 has provided care for less than 50 unique insurance policy holders
competent health insurance company.
4. the health insurance company may provide medical facility for 1. and
2. half of 2008 interim payment equal to 103% of remuneration in
the half-year 2007.
1) Council Regulation (EEC) No 1408/71 of 14 June. June 1971 on the application of
of social security schemes to employed persons and their families
moving within the community and Council Regulation (EEC) No 574/72 of the Council
on 21 February 2006. in March 1972, laying down detailed rules for the application of regulation
(EEC) No 1408/71 on the application of social security schemes to
employed persons and their families moving within the community.
2) for example, the communication from the Ministry of Foreign Affairs No. 130/2002 Coll., m.
with the negotiation of the Treaty, between the Czech Republic and the Federal Republic of
Yugoslavia on social security, the communication of the Ministry of foreign
No 83/2000 Sb. m. s., on the negotiation of a Treaty between the Czech Republic and
The Republic of Croatia on social security, the Ministry of communication
Foreign Affairs No 135/2004 Coll., m. s., the negotiation of the agreement between the Czech
Republic and the Republic of Turkey concerning social security, communications
Ministry of Foreign Affairs No. 2/2007 Sb. m. s., the negotiation of the Treaty
between the Czech Republic and the Republic of Macedonia concerning social security.
3) Decree No. 134/1998 Coll. issuing the list of medical procedures
with point values, as amended.
4) section 10 of Act No. 526/1990 Coll., on prices, as amended by the Act No. 261/2007
SB.
5) the communication from the CZECH STATISTICAL OFFICE No. 309/2007 Coll., on the updating of the classification
hospitalized patients (IR-DRG).
6) Decree No 63/2007 Coll., on transfers of medicines and foods for special
medical purposes.